<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2025.1595706</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Multiple analytical perspectives of mitochondrial genes in the context of preeclampsia: potential diagnostic markers</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Can</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Fang</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Chao</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1307981/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Xiangzhong</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1842987/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lv</surname>
<given-names>Qiulan</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1605808/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Aiping</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhao</surname>
<given-names>Shuping</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3005306/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Obstetrics and Gynecology, Qingdao Women and Children&#x2019;s Hospital, Shandong University</institution>, <addr-line>Jinan, Shandong</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University</institution>, <addr-line>Qingdao, Shandong</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Obstetrics and Gynecology, Dazhou Dachuan District People&#x2019;s Hospital (Dazhou Third People&#x2019;s Hospital)</institution>, <addr-line>Dazhou, Sichuan</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Medical Research Center, The Affiliated Hospital of Qingdao University</institution>, <addr-line>Qingdao, Shandong</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Rajni Kant, Kaohsiung Medical University, Taiwan</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Panicos Shangaris, King&#x2019;s College London, United Kingdom</p>
<p>Ling Bai, Duke University, United States</p>
<p>Lokanatha Oruganti, Tulane University, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Shuping Zhao, <email xlink:href="mailto:zhaosp66@126.com">zhaosp66@126.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>07</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1595706</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>03</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Li, Liu, Li, Zhao, Lv, Jiang and Zhao</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Li, Liu, Li, Zhao, Lv, Jiang and Zhao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Preeclampsia(PE) is closely linked to adverse maternal and fetal outcomes. Given the pivotal roles of mitochondria in various human diseases and the limited research on their involvement in PE, this study identified biomarkers linked to mitochondrial metabolism in PE and their roles in its pathogenesis. Data from three datasets were integrated using the ComBat algorithm to mitigate batch effects. Differential expression analysis identified genes differentially expressed between PE cases and Control group. Cross-referencing these genes with mitochondrial energy metabolism-related genes (MMRGs) isolated mitochondrial energy metabolism-related differentially expressed genes (MMRDEGs). GO and KEGG analysis were performed to elucidate the functions of the MMRDEGs. A diagnostic model using Random Forest and logistic regression was validated by ROC curve analysis. mRNA expressions of <italic>OCRL</italic>, <italic>TPI1</italic>, <italic>GAPDH</italic>, and <italic>LDHA</italic> were quantified via qPCR. Immune characteristics were explored, and PPI, mRNA-miRNA, mRNA-TF and mRNA-RBP interaction networks were constructed. AlphaFold analyzed protein structures of <italic>OCRL, TPI1, GAPDH</italic>, and <italic>LDHA.</italic> A total of 1073 DEGs and 24 MMRDEGs were identified. <italic>OCRL, TPI1, GAPDH</italic>, and <italic>LDHA</italic> formed the diagnostic model, which were predominantly enriched in pyruvate metabolism, glycolysis, and ATP metabolism pathways. CIBERSORT highlighted immune cell composition variations between PE and Control groups. <italic>OCRL, TPI1, GAPDH</italic>, and <italic>LDHA</italic> exhibited increased mRNA expression levels in preeclamptic placentas. Therefore, MMRDEGs may play a critical role in the mechanism of oxidative stress and inflammatory response in PE by mediating metabolic regulation and immune modulation, potentially serving as diagnostic biomarkers associated with mitochondrial metabolism in preeclampsia.</p>
</abstract>
<kwd-group>
<kwd>preeclampsia</kwd>
<kwd>mitochondria-related genes</kwd>
<kwd>diagnostic model</kwd>
<kwd>machine learning</kwd>
<kwd>immune cells infiltration</kwd>
</kwd-group>
<counts>
<fig-count count="10"/>
<table-count count="0"/>
<equation-count count="3"/>
<ref-count count="138"/>
<page-count count="23"/>
<word-count count="11973"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Systems Immunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Preeclampsia (PE) is a pregnancy-related multisystem syndrome that occurs at or after 20 week of gestation, characterized by elevated blood pressure (systolic blood pressure &#x2265;140 mmHg and/or diastolic blood pressure &#x2265;90 mmHg) and proteinuria (&#x2265;300 mg/24h). This condition can lead to multiple organ dysfunctions, including hematological abnormalities, hepatic impairment, and renal insufficiency. In severe cases, it may also compromise pulmonary function, retinal health, and the integrity of the central nervous system (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B4">4</xref>). PE is one of the leading causes of maternal mortality globally, with an estimated prevalence of approximately 10% (<xref ref-type="bibr" rid="B5">5</xref>). Its pathogenesis is closely associated with placental vascular insufficiency, endothelial dysfunction, heightened inflammatory responses, immune imbalance, and systemic small-vessel spasms (<xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>). Currently, the management of PE primarily relies on blood pressure control and timely pregnancy termination (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). However, the limited availability of preventive and intervention strategies leads to a high incidence of iatrogenic preterm birth, thus increasing the risk of adverse perinatal outcomes. Therefore, an in-depth exploration of the pathogenesis of PE is essential for reducing its incidence and improving prognostic outcomes.</p>
<p>Mitochondria play a pivotal role in cellular bio-oxidation and energy metabolism, being involved in a range of physiological processes including biosynthesis and signal transduction (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). Therefore, mitochondrial dysfunction disrupts these processes, resulting in elevated generation of reactive oxygen species (ROS) and enhanced apoptosis (<xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B15">15</xref>). As a critical organ for maternal-fetal material exchange, synthesis, defense, and immunity, the placenta exhibits a high demand for energy, primarily supplied by ATP generated by mitochondria (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). If mitochondrial function diminished, ATP synthesis will consequently decrease, thereby impairing placental function and increasing the risk of complications such as preeclampsia (PE), gestational diabetes mellitus(GDM), and fetal growth restriction(FGR) (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Numerous studies have demonstrated that elevated levels of oxidative stress in patients with PE contribute to the promotion of inflammatory responses and mitochondrial dysfunction (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Research further suggests that mitochondrial dysfunction plays a critical role in both the onset and progression of PE. For instance, Long et&#xa0;al. (<xref ref-type="bibr" rid="B22">22</xref>)reported that mitochondrial damage leads to trophoblast dysfunction, which in turn contributes to the pathogenesis of PE. These findings suggest that targeting mitochondrial repair could represent a promising therapeutic strategy for managing this condition. In addition, several mitochondria-associated genes, such as <italic>CPOX</italic>, <italic>DEGS1</italic>, and <italic>SH3BP5</italic>, have been validated to possess significant diagnostic value for PE (<xref ref-type="bibr" rid="B18">18</xref>). Mitochondria harbor an independent genome distinct from nuclear DNA (<xref ref-type="bibr" rid="B23">23</xref>), and alterations in the expression of specific mitochondrial genes have been identified as being closely linked to the diagnosis and treatment of PE (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). In recent years, accumulating evidence has demonstrated that immune cell infiltration is a critical factor in the pathogenesis of various diseases, including PE, preterm birth, GDM, and osteoarthritis (<xref ref-type="bibr" rid="B26">26</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>).</p>
<p>Owing to the multifaceted nature of PE, there has been relatively limited progress in its prediction and prevention (<xref ref-type="bibr" rid="B29">29</xref>). Given the pivotal role of mitochondrial energy metabolism in various diseases, further exploration into the mechanisms of mitochondrial energy metabolism in PE carries significant clinical implications. This study is expected to offer a theoretical basis and innovative perspectives for the early diagnosis and therapeutic intervention of PE. In this study, we aimed to utilize machine learning techniques to construct an innovative diagnostic model for PE and investigate the association between key differentially expressed genes (DEGs) and immune infiltration. Additionally, we validated the expression levels of these DEGs in placental tissues from PE patients, thereby highlighting their potential significance in the pathophysiological mechanisms underlying PE.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methodologies</title>
<sec id="s2_1">
<label>2.1</label>
<title>Sample collection</title>
<p>In this research, 20 PE placental tissues, among which 12 cases with severe features, were collected following cesarean sections, with diagnosis conforming to the guidelines established by the Task Force on Hypertension in Pregnancy. Correspondingly, control placental tissues (n=20), matched for age and body mass index (BMI), were also obtained. All placental tissues were sourced from pregnant women who delivered at the Affiliated Hospital of Qingdao University. Because gestational diabetes mellitus (GDM) is associated with an increased incidence of PE (<xref ref-type="bibr" rid="B30">30</xref>), exclusion criteria for the research were as follows: twin or multiple pregnancies; fetal structural abnormalities or chromosomal anomalies; the presence of comorbidities or complications including GDM, pre-pregnancy diabetes mellitus, chronic hypertension, cardiac, renal, or liver diseases, infectious diseases, or autoimmune disorders; history of blood transfusion, organ transplantation, or immunotherapy; and any history of smoking, alcohol consumption, or substance abuse. Basic clinical data were collected for this study, encompassing age, BMI, gestational week at delivery, parity, systolic and diastolic blood pressure, newborn weight, and one-minute Apgar score. A sample of maternal placental tissue, approximately 1&#xa0;cm in diameter, was collected within ten minutes of placental delivery, specifically avoiding areas with infarcts or calcification. These samples were then placed in freezing tubes containing RNA preservation solution and kept at -80&#xb0;C for subsequent analysis using RT-qPCR. All the participants of the study provided a written informed consent. The investigation was approved by the Ethics Committee of the Affiliated Hospital of Qingdao University (Approval No: QYFY WZLL 28705). It was carried out in rigorous adherence to the guidelines established by the committee.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Data download</title>
<p>The expression profile datasets GSE24129 (<xref ref-type="bibr" rid="B31">31</xref>), GSE30186 (<xref ref-type="bibr" rid="B32">32</xref>), GSE54618 (<xref ref-type="bibr" rid="B33">33</xref>) and GSE75010 (<xref ref-type="bibr" rid="B34">34</xref>) of patients with PE were obtained from GEO database (<xref ref-type="bibr" rid="B35">35</xref>) utilizing the GEOquery package (<xref ref-type="bibr" rid="B36">36</xref>). The GSE24129 dataset included 16 placental samples, evenly distributed between 8 PE cases and 8 Control group. The GSE30186 dataset comprised 12 placental samples, with an equal number of PE cases and Control group. The GSE54618 dataset consisted of 17 placental samples, including 5 from PE cases and 12 from Control group. Lastly, the GSE75010 dataset contained 80 PE cases and 77 Control group. The dataset GSE24129 and GSE75010 utilized the GPL6244 [HuGene-1_0-st-v1] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version]. For the datasets GSE30186 and GSE54618, the associated platform was the GPL10558 Illumina HumanHT-12 V4.0 expression beadchip. The microarray GPL platform files facilitated related annotation for the probe names across these datasets. Specific information for each dataset is depicted in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>. Utilizing &#x201c;mitochondrial energy metabolism&#x201d; as the search keyword and focusing solely on protein-coding genes, we extracted 219 MMRGs from the datebase of GeneCards (<ext-link ext-link-type="uri" xlink:href="https://www.genecards.org/">https://www.genecards.org/</ext-link>),which offers extensive data on the human genes (<xref ref-type="bibr" rid="B37">37</xref>). Additionally, we derived 188 MMRGs from the published literature (<xref ref-type="bibr" rid="B38">38</xref>). By integrating these datasets and removing duplicates, we compiled a consolidated list of 384 MMRGs. The specific names of these genes are listed in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref>.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Preprocessing the datasets and differential expression analysis</title>
<p>We integrated the GSE24129, GSE30186 and GSE54618 datasets and then eliminated batch effects by applying the ComBat algorithm from the R package (<xref ref-type="bibr" rid="B39">39</xref>), followed by normalization using the normalize Between Arrays function. Thus, the Combined dataset (including 19 PE cases and 26 Control group) was obtained. Subsequently, we obtained DEGs by utilizing R&#x2019;s limma package to carry out a differential analysis of the expression of all genes among the PE and the control cohort samples of the combined dataset. To make sure to capture all changes in expression levels, whether up-regulated or down-regulated, we made a screening standard of p &lt; 0.05 plus | logFC | &gt; 0 to further study the DEGs (<xref ref-type="bibr" rid="B40">40</xref>). The findings of variance analysis through the R package ggplot2 map volcano to display. Then, we took MMRGs and DEGs intersection to obtain the MMRDEGs.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>GO and KEGG analysis</title>
<p>The GO (<xref ref-type="bibr" rid="B41">41</xref>) approach is frequently employed in large-scale functional enrichment investigations for the purpose of categorizing genes into groups that are associated with biological process (BP), molecular function (MF), and cellular component (CC). The KEGG (<xref ref-type="bibr" rid="B42">42</xref>) serves as a crucial repository for genomic information, diseases, drug-related data and biological pathways. We conducted GO and KEGG annotation analyses of MMRDEGs by employing the R package clusterProfiler (<xref ref-type="bibr" rid="B43">43</xref>). We set a marked threshold (<italic>p &lt; 0.05</italic>) for pathway selection, ensuring that only statistically significant pathways were considered in our analysis.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>GSEA and GSVA analysis</title>
<p>GSEA (<xref ref-type="bibr" rid="B44">44</xref>) is a widely utilized method for assessing variations in pathway activity and biological process involvement across different sample groups within an expression dataset. In this research, we initially carried out a differential gene expression analysis between various groups (PE/Control and High/Low Risk score) within the combined dataset. Subsequently, genes were categorized into two cohorts based on their logFC values: those with positive and those with negative logFC. For the enrichment analysis of these categorized genes, we utilized the clusterProfiler package. The GSEA configuration for this analysis utilized the following specifications: a seed of 2022, 1000 permutations, and a gene set size ranging from a minimum of 10 to a maximum of 500 genes. We retrieved the gene set &#x201c;c2.Cp.All.V2022.1.Hs.Symbols.GMT [All Canonical Pathways]&#x201d; containing 3050 entries from the Molecular Signatures Database (MSigDB) (<xref ref-type="bibr" rid="B45">45</xref>). Pathways which got a significant enrichment level (<italic>p &lt; 0.05)</italic> were deemed markedly enriched.</p>
<p>GSVA (<xref ref-type="bibr" rid="B46">46</xref>) was designed to assess gene set enrichment within microarray and nuclear transcriptome data. This technique enables the conversion from diverse samples into a sample-specific gene expression matrix and can evaluate the pathway enrichment across multiple specimens. In this study, we also employed the gene set used earlier when GSEA analysis was performed. GSVA was carried out on gene expression matrices derived from distinct groups (PE/Control or High/Low Risk score) within the Combined dataset, utilizing this reference gene set. The analysis revealed functional disparities in enriched pathways between sample cohorts within the Combined dataset. Pathways with a significance level (<italic>p &lt; 0.05</italic>) were further scrutinized; specifically, we selected and examined the 10 pathways exhibiting both the largest and smallest log fold change (logFC).</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Construct MMRDEGs diagnostic model</title>
<p>The RandomForest (RF) (<xref ref-type="bibr" rid="B47">47</xref>) technique is a collective learning approach that integrates numerous decision tree models. It belongs to the bagging (bootstrap aggregation) ensemble algorithm, which consists of multiple algorithms. RF is a commonly used approach for model building. By constructing multiple decision trees, the prediction results of each tree in the forest are aggregated using a voting method to obtain the final prediction result for a given sample. In this study, we utilized the MMRDEGs expression levels in the Combined dataset&#x2019;s expression matrix to build a model using the RandomForest package with parameter set.seed (2023) and ntree = 1000.</p>
<disp-formula>
<mml:math display="block" id="M1">
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mi>X</mml:mi>
<mml:mo>=</mml:mo>
<mml:mi>x</mml:mi>
<mml:mi>i</mml:mi>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mo>=</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>l</mml:mi>
<mml:mi>o</mml:mi>
<mml:msub>
<mml:mi>g</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>p</mml:mi>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>x</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
<p>We conducted a logistic regression analysis on MMRDEGs to construct a Logistic diagnostic model of the Combined dataset. Moreover, we employed the Logistic regression to analyze the association of the independent variables and dependent variables, when considering dependent variables as binary variables(PE cases and Control group). <italic>p</italic> &lt; 0.05 was a significance level as criteria for identifying MMRDEGs and constructing the Logistic diagnostic model. The molecular expressions of MMRDEGs incorporated in this logistic regression model were visualized through Forest Plot.</p>
<p>Furthermore, we conducted the Least Absolute Shrinkage and Selection Operator (LASSO, the seed number is 2022) by R package glmnet (<xref ref-type="bibr" rid="B48">48</xref>) to process the MMRDEGs, which were screened out by utilizing our logistic regression model, to obtain the Logistic-LASSO regression model. LASSO regression analysis reduces overfitting incorporating a penalization factor (lambda &#xd7; absolute value of slope), thereby improving its capacity for generalization while maintaining interpretability. The results obtained from LASSO analysis were depicted through variable trajectory plot techniques and diagnostic model plot.</p>
<disp-formula>
<mml:math display="block" id="M2">
<mml:mrow>
<mml:mtext>risk</mml:mtext>
<mml:mi>S</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>=</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:munder>
<mml:mo>&#x2211;</mml:mo>
<mml:mi>i</mml:mi>
</mml:munder>
<mml:mi>C</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>f</mml:mi>
<mml:mi>f</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mi>h</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>b</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>g</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:msub>
<mml:mi>e</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mo>*</mml:mo>
<mml:mi>m</mml:mi>
<mml:mi>R</mml:mi>
<mml:mi>N</mml:mi>
<mml:mi>A</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>E</mml:mi>
<mml:mi>x</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mi>h</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>b</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>g</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:msub>
<mml:mi>e</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
<p>Subsequently, we identified the common MMRDEGs by intersecting the MMRDEGs derived from both the RF model and the Logistic-LASSO regression model, which were then visualized using a Venn diagram. The expression levels of the common MMRDEGs in the Combined dataset were combined with the coefficients of these genes in the regression model of Logistic-LASSO to establish an MMRDEGs diagnostic model and to calculate corresponding Risk-scores. A Nomogram (<xref ref-type="bibr" rid="B49">49</xref>), a visual depiction of interrelations among several independent variables on a rectangular plane-coordinate system, was constructed based on the gene expression levels derived from the MMRDEGs diagnostic model generated through Logistic LASSO regression analysis in the Combined dataset. To examine the precision and distinguishing capability of our MMRDEGs diagnostic models, Decision Curve Analysis (DCA) (<xref ref-type="bibr" rid="B50">50</xref>), a straightforward approach for appraising molecular markers, diagnostic tests and clinical prediction models, was performed using the ggDCA R package.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Analysis of the infiltration of immune cells</title>
<p>The relative abundance of a variety of immune cell infiltrates within every sample was quantified utilizing the single-sample gene-set enrichment analysis (ssGSEA) algorithm. The method facilitated to label various immune cell types. For instance, regulatory T cells, CD8<sup>+</sup> T cells, dendritic cells and macrophages. We represented the relative abundance of each immune cell type across the samples by enrichment scores, which were calculated utilizing ssGSEA methodology (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). Using the ssGSEA algorithm from the GSVA R package (version 1.46.0), we calculated the enrichment scores of groups within high and low risk cohorts according to the MMRDEGs diagnostic model from the Combined dataset. These scores depicted the extent of immune cell infiltrations in individual specimen, thereby illustrating disparities of the abundance of immune cell infiltration among the different (High and Low) risk cohorts through box plots. Additionally, we examined the correlation of immune cell abundances among the high and low risk cohorts utilizing scatter plots. The association among immune cells and commonly altered MMRDEGs across these groups was analyzed using the Spearman statistical method and depicted in correlation dot plots, increasing our understandings of the immune landscape in relation to preeclampsia risk stratification.</p>
<p>CIBERSORT (<xref ref-type="bibr" rid="B53">53</xref>) is a kind of immune infiltration algorithm, that deconvoluted transcriptome expression matrices based on linear support vector regression, to assess the abundance and composition of immune cells within different samples. For this analysis, we input the expression matrix data of samples of the High and the Low risk groups defined by the MMRDEGs diagnostic model in the Combined dataset to CIBERSORT. Using the feature gene matrix of LM22, we refined the results by retaining solely those data points with immune cell enrichment scores &gt;0, thus obtaining and visualizing the comprehensive findings of the immune cell infiltration abundance matrix. Those disparities in immune cell infiltration between the high risk and low risk cohorts were depicted utilizing stacked bar charts. We employed the Spearman statistical method to analyze the correlations among immune cells within the Combined dataset and utilized the R package ggplot2 to visualize the results. Moreover, the interactions among immune cells and commonly altered MMRDEGs were depicted using correlation dot plots, providing insights into the immune dynamics associated with different risk stratifications in PE.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>PPI network and mRNA-RBP, mRNA-TF, mRNA-Drug interaction network</title>
<p>The protein-protein interaction (PPI) network consists of individual proteins that engage with one another. In this study, we constructed the common MMRDEGs PPI network(minimum required interaction score: low confidence (0.150)) using the database of STRING (<xref ref-type="bibr" rid="B54">54</xref>). The network was visualized using Cytoscape, which allowed us to identify densely interconnected clusters within the PPI network. These clusters potentially signify molecular assemblies with unique biological roles, offering insights into the molecular mechanisms underlying PE.</p>
<p>ENCORI database (<xref ref-type="bibr" rid="B55">55</xref>) (<ext-link ext-link-type="uri" xlink:href="https://starbase.sysu.edu.cn/">https://starbase.sysu.edu.cn/</ext-link>) facilitates the exploration of interactions among various RNA types, including microRNAs-ncRNA, microRNAs-mRNA, ncRNA-RNA, and RNA-RNA, as well as interactions among RNA-binding proteins (RBPs) and ncRNAs or mRNAs. These interactions are curated utilizing degradome sequencing data and CLIP-seq, supporting comprehensive visual tools of investigating miRNA targets. In our study, we utilized the ENCORI database to forecast RBPs interacting with the commonly altered MMRDEGs. We established &#x201c;pancancerNum&gt; 27&#x201d; as the threshold for selecting significant interactions. and the mRNA-RBP interaction network was rendered utilizing Cytoscape.</p>
<p>HTFtarget database (<xref ref-type="bibr" rid="B56">56</xref>) (<ext-link ext-link-type="uri" xlink:href="http://bioinfo.life.hust.edu.cn/hTFtarget">http://bioinfo.life.hust.edu.cn/hTFtarget</ext-link>) integrates human transcription factors (TFs) and their corresponding control targets data. The CHIPBase database (<ext-link ext-link-type="uri" xlink:href="https://rna.sysu.edu.cn/chipbase/">https://rna.sysu.edu.cn/chipbase/</ext-link>) predicted transcriptional regulatory relationships among millions of TFs and genes. Utilizing both HTFtarget databases and CHIPBase, the TFs that link to common MMRDEGs were identified. We applied the screening criteria of having an upstream and downstream sample count greater than zero. Subsequently, the mRNA-TF interactive network was rendered visually utilizing Cytoscape software.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>RT-qPCR</title>
<p>Placental tissues were lysed using FreeZol reagent (Vazyme, R711) following the manufacturer&#x2019;s instructions. RNA concentration and purity were measured using a spectrophotometer. The isolated RNA was reverse transcribed into cDNA with a reverse transcription kit (Agbio, AG11705). Real-time polymerase chain reaction (qPCR) was then performed using the SYBR Green Pre-Mix Pro Taq HS qPCR Kit (Agbio, AG11701). Relative gene expression levels were normalized to <italic>&#x3b2;-actin</italic> and calculated using the 2^<sup>(-&#x394;&#x394;Ct)</sup> method. The <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref> lists the primer sequences of mRNAs and internal control.</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Statistical analysis</title>
<p>The entirety of data manipulation and statistical evaluation in this investigation was executed utilizing R software (Release 4.1.2). The independent Student&#x2019;s t-test was used to compare continuous variables (fit normal distribution). We employed the Mann-Whitney U test (Wilcoxon rank sum test) for variables lacking normally distributed. Use Spearman correlation analysis to computer the findings unless otherwise specified. The p-values for statistical tests are two-tailed, and a threshold of 0.05 is deemed indicative of statistically meaningful results.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Dataset processing</title>
<p>According to the technical roadmap of this experiment (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>), we first combined the three datasets (GSE24129, GSE30186, and GSE54618), then batched the data using the ComBat function from R&#x2019;s sva package, and then utilized the Normalize Between Arrays function of the limma package to perform standardization procedures. The dataset of 19 PE cases and 26 Control group, that was combined, was obtained.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Technology roadmap. PE, Preeclampsia; GSEA, Gene Set Enrichment Analysis; GSVA, Gene Set Variation Analysis; MMRGs, Mitochondrial energy metabolism-related genes; MMRDEGs, Mitochondrial energy metabolism related differentially expressed genes; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; LASSO, Least absolute shrinkage and selection operator; RBP, RNA binding protein; TF, Transcription factors; ssGSEA, single-sample gene-set enrichment analysis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1595706-g001.tif">
<alt-text content-type="machine-generated">Flowchart illustrating a research process. Datasets GSE24129, GSE30186, and GSE54618 are combined. Expression difference analysis compares PE vs Control. MMRDEGs undergo Random Forest and Logistic &amp; LASSO analysis. Results yield Common MMRDEGs and constructs a risk score group (High/Low). GO and KEGG are used for analysis. GSEA and GSVA are performed for both PE vs Control and High vs Low. Immune analysis includes ssGSEA and CIBERSORT. PPI network is evaluated for mRNA-RBP, mRNA-TF, and mRNA-Drug interactions.</alt-text>
</graphic>
</fig>
<p>The before and after data processing boxplots and PCA plots of the combined dataset, according to the sample source, were showed in the <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1A&#x2013;D</bold>
</xref>, respectively. The findings demonstrated that the expression profiles of samples from the Combined dataset exhibited a high degree of consistency, indicating successful removal of batch effects through data processing. The Combined dataset utilized for subsequent analyses represented the batch effect-corrected and normalized data.</p>
<p>We further utilized the limma package to standardize the GSE75010 dataset and compared the pre- and post-processing states of the dataset using boxplots (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1E, F</bold>
</xref>). The boxplot analysis demonstrated that the expression levels of samples in the GSE75010 dataset became significantly more consistent after data processing.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Combined dataset differential expression analysis of PE and control groups</title>
<p>The placenta serves as a critical organ facilitating material transport between mother and fetus, performing multiple functions during pregnancy such as immune protection, endocrine regulation, and serving as a conduit for nutrient and oxygen delivery. Its condition is closely associated with the health of both mother and child during gestation. Torbergsen T et&#xa0;al. first described a high incidence of preeclampsia in a family with mitochondrial disorder (<xref ref-type="bibr" rid="B57">57</xref>). Recent research into the mechanisms underlying preeclampsia has revealed mitochondrial dysfunction in both patients with preeclampsia and animal models (<xref ref-type="bibr" rid="B58">58</xref>).</p>
<p>We utilized limma package to explore the Combined dataset of PE cases and Control group. And we got 1073 differentially expressed genes using the threshold of | logFC | &gt; 0 and <italic>p</italic> &lt; 0.05, including 603 highly expressed genes in PE cases(the Control group of samples low expressed, logFC is positive, raised genes), and 470 genes low expressed in PE cases(the Control group of samples increased, logFC is negative, cut genes). And then, we presented the outcomes of differential expression analysis between the two groups in the Combined dataset using the volcano plot (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). We then intersected these 1073 differently expressed genes (DEGs) with 384 mitochondrial energy metabolism-related genes (MMRGs). And then, 24 mitochondrial energy metabolism-related differentially expressed genes (MMRDEGs) were identified. The 24 MMRDEGs were <italic>ACSL3</italic>, <italic>ALDH16A1</italic>, <italic>ALDH1A3</italic>, <italic>ALDH4A1</italic>, <italic>ATG7</italic>, <italic>BTD</italic>, <italic>FBXL4</italic>, <italic>FOXO1</italic>, <italic>GAPDH</italic>, <italic>GLS</italic>, <italic>HK2</italic>, <italic>KCNJ2</italic>, <italic>LDHA</italic>, <italic>MFN2</italic>, <italic>NDUFS6</italic>, <italic>OCRL</italic>, <italic>PC</italic>, <italic>PGK1</italic>, <italic>PPARG</italic>, <italic>RARS2</italic>, <italic>SOD1</italic>, <italic>TPI1</italic>, <italic>VDAC1</italic>, <italic>XBP1</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Differential expression analysis and correlation analysis of MMRDEGs. <bold>(A)</bold> Volcano plot presentation of the results of differential analysis between PE cases and Control group in Combined datasets. <bold>(B)</bold> Venn diagram of DEGs between PE cases and Control group and MMRGs in Combined datasets. <bold>(C)</bold> Group comparison plot of MMRDEGs between PE cases and Control group in Combined datasets. <bold>(D)</bold> Simplified numerical heatmap of MMRDEGs in Combined datasets. <bold>(E)</bold> Chromosomal mapping of MMRDEGs. The symbol ns was equivalent to <italic>p &#x2265; 0.05</italic>, which was not statistically significant. The symbol * is equivalent to <italic>p &lt; 0.05</italic>, which is statistically significant; The symbol ** is equivalent to <italic>p &lt; 0.01</italic>, which is highly statistically significant; The symbol *** is equivalent to <italic>p &lt; 0.001</italic> and highly statistically significant. PE, Preeclampsia; DEGs, differentially expressed genes; MMRGs, Mitochondrial energy metabolism related genes; MMRDEGs, Mitochondrial energy metabolism related differentially expressed genes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1595706-g002.tif">
<alt-text content-type="machine-generated">Graphical summary of gene expression analysis:  A) Volcano plot showing significant gene expression changes with upregulated, downregulated, and non-significant genes.  B) Venn diagram highlighting overlap between MMRGs and DEGs.  C) Box plots comparing gene expressions between control and PE across multiple genes, showing statistical significance.  D) Heatmap illustrating expression patterns of selected genes under different conditions.  E) Circos plot displaying the chromosomal distribution of selected genes.</alt-text>
</graphic>
</fig>
<p>We also generated a comparative map to analyze the differential expression of 24 MMRDEGs between the two cohorts (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). The analysis suggested that 16 MMRDEGs exhibited significant differences, with <italic>ALDH16A1</italic>, <italic>ALDH4A1</italic>, <italic>ATG7</italic>, <italic>GLS</italic> and <italic>SOD1</italic> significantly down-regulated while <italic>ALDH1A3</italic>, <italic>BTD</italic>, <italic>FOXO1</italic>, <italic>GAPDH</italic>, <italic>HK2</italic>, <italic>KCNJ2</italic>, <italic>LDHA</italic>, <italic>OCRL</italic>, <italic>PGK1</italic>, <italic>TPI1</italic>, and <italic>VDAC1</italic> significantly up-regulated.</p>
<p>Then, we drew a simple numerical heat map derived from the expression matrix of these 16 MMRDEGs above (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>), and the visualization revealed substantial disparities in the expression patterns of the 16 MMRDEGs between the two sample groups. Additionally, we annotated the positions of these 16 MMRDEGs and draw a chromosome localization map (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>) by employing the RCircos package, from which the specific distribution of the 16 MMRDEGs on each chromosome can be obtained.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>The GO and the KEGG analysis of MMRDEGs</title>
<p>The biological processes (BP), molecular functions (MF), cellular components (CC), relationships between biological pathways, pathway enrichment analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG), and gene function enrichment analysis based on Gene Oncology (GO) were carried out to analyze the 16 MMRDEGs. Pathways that below the <italic>P</italic> threshold of 0.05, were considered to be statistically significant. The outcomes showed that the 16 MMRDEGs main enriched in those BPs, such as pyruvate metabolic process, glycolytic process, ATP generation from ADP, generation of precursor metabolites and energy, ATP metabolic process. And in the CCs of the mitochondrial matrix. It was enriched in acting on the aldehyde or oxo group of donors, oxidoreductase activity, NAD or NADP as acceptor, aldehyde dehydrogenase (NAD+) activity, aldehyde dehydrogenase [NAD(P)+] activity, protein phosphatase binding, oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor and other MFs (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). It was also enriched in Glycolysis/Gluconeogenesis, HIF-1 signaling pathway, Carbon metabolism, Alanine, aspartate, glutamate metabolism, Inositol phosphate metabolism (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>) and other KEGG pathways (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;4</bold>
</xref>). In addition, the enrichment consequences of the BP pathways (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>), CC pathways (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>), MF pathways (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>), and KEGG pathways (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>) of GO analysis were presented utilizing ring network diagrams.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Functional enrichment analysis (GO) and pathway enrichment (KEGG) analysis of MMRDEGs. <bold>(A)</bold> Bar graph showing the GO enrichment analysis results of MMRDEGs. <bold>(B)</bold> Bubble plot display of KEGG pathway enrichment analysis results of MMRDEGs. <bold>(C&#x2013;F)</bold> Loop network diagram of BP pathway <bold>(C)</bold>, CC pathway <bold>(D)</bold>, MF pathway <bold>(E)</bold> and KEGG pathway <bold>(F)</bold> in MMRDEGs enrichment analysis results. In the bar graph <bold>(A)</bold>, the abscissa is the GO terms, and the height of the bar indicates the Padj value of GO terms. In the network diagram <bold>(C&#x2013;F)</bold>, blue dots represent specific genes, and orange dots represent specific pathways. MMRDEGs, Mitochondrial energy metabolism related differentially expressed genes; GO, Gene Ontology; BP, biological process; CC, cellular component; MF, molecular function; KEGG, Kyoto Encyclopedia of Genes and Genomes; The screening criterion for GO/KEGG enrichment items was <italic>p &lt; 0.05</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1595706-g003.tif">
<alt-text content-type="machine-generated">A set of six panels illustrating gene ontology and pathway analysis. Panel A shows a bar chart categorizing biological processes (BP), cellular components (CC), and molecular functions (MF) with variable significance levels. Panel B is a bubble chart displaying pathway enrichment, with the size and color of bubbles indicating gene ratio and adjusted P-values, respectively. Panels C to F present network graphs depicting interactions between genes and pathways for different ontologies and pathways, each showing node sizes based on counts. The graphs highlight key metabolic processes and components involved in metabolic pathways.</alt-text>
</graphic>
</fig>
<p>We utilized the Pathview R package for pathway mapping to illustrate the KEGG enrichment results of Glycolysis/Gluconeogenesis (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>), Carbon metabolism (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2B</bold>
</xref>), Alanine, aspartate and glutamate metabolism (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2C</bold>
</xref>), Inositol phosphate metabolism (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2D</bold>
</xref>), and HIF-1 signaling pathway (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2E</bold>
</xref>).</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>GSEA enrichment analysis and GSVA analysis of the control and the PE groups based on the Combined dataset</title>
<p>To appraise the influence of gene expression levels of genes from PE and Control groups of Combined dataset on PE, we examined the relationships between the expression levels of all genes in different groups (PE/Control) of the Combined dataset and the BPs, CCs, and MFs they played, by employing the Gene Set Enrichment Analysis (GSEA). <italic>p &lt; 0.05</italic> was set as the significant enrichment criterion. The results demonstrated a significant enrichment of genes from different (PE/Control) groups in the Combined dataset, specifically in the vascular smooth muscle contraction pathway (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>), IL9 signaling pathway (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>), Notch signaling pathway (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>), IL2 signaling pathway (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>), IL6/7 signaling pathway (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>), cell surface interactions at the vascular wall (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4G</bold>
</xref>), and other pathways (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;5</bold>
</xref>). In addition, the outcomes of GSEA analyzing genes between distinct cohorts (PE/Control) of the Combined dataset were depicted by mountain plot (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>GSEA enrichment analysis between PE cases and Control group in Combined dataset. <bold>(A)</bold> Six main biological characteristics of GSEA enrichment analysis of genes between different groups (PE/Control) of Combined dataset. <bold>(B&#x2013;G)</bold> Genes in Combined dataset were significantly enriched in KEGG vascular smooth muscle contraction <bold>(B)</bold>, IL9 signaling pathway <bold>(C)</bold>, KEGG NOTCH signaling pathway <bold>(D)</bold>, IL2 signaling pathway <bold>(E)</bold>, IL6/7 pathway <bold>(F)</bold>, Cell surface interactions at the vascular wall <bold>(G)</bold>. PE, Preeclampsia; GSEA, Gene Set Enrichment Analysis. The significant enrichment screening criterion for GSEA enrichment analysis was <italic>p &lt; 0.05</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1595706-g004.tif">
<alt-text content-type="machine-generated">Graphical summary of pathway analysis showing enrichment scores and significance levels for multiple pathways. Panel A displays a heatmap with normalized enrichment scores (NES) and p-values for six pathways: KEGG Vascular Smooth Muscle Contraction, WikiPathways IL9 Signaling, KEGG Notch Signaling, WikiPathways IL2 Signaling, PID IL6 7 Pathway, and Reactome Cell Surface Interactions. Panels B to G provide detailed enrichment plots for each pathway, illustrating enrichment scores against rank in the ordered dataset, with corresponding NES and p-values.</alt-text>
</graphic>
</fig>
<p>To investigate the distinctions between disease and controls from the Combined dataset, we then performed Gene Set Variation Analysis (GSVA). From the pathways with <italic>p &lt; 0.05</italic>, we identified 10 pathways with the highest and lowest logFC for further examination (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;6</bold>
</xref>), respectively.</p>
<p>The results of GSVA analysis on all the genes of the Combined dataset revealed significant differences among PE and Control groups. Specifically, IKEDA Mir133 targets DN, hyaluronan biosynthesis and export, RHOT1 GTPASE cycle, neurofascin interactions, Irinotecan pathway, Aflatoxin B1 metabolism, Sulindac metabolic pathway, weber methylated LCN in SPERM DN, Tomlins metastasis upregulation of steroid biosynthesis. Additionally, activated NTRK2 signals through FYN and PI3K pathways were observed along with NTRK2 activation of RAC1. Furthermore, HIF1A and PPARG were found to regulate glycolysis. Calvet Rinotecan sensitive vs resistant upregulation was also identified as well as Korkola choriocarcinoma involvement. Lastly erythrocytes demonstrated oxygen uptake and carbon dioxide release while Tesar Alk targeted human es 4D and 5D DN along with JAK targeting mouse es D4 DN. Utilizing the outcomes derived from GSVA, we carried out a differential expression analysis of 20 pathways among PE and control cohorts of the Combined dataset. Subsequently, we created a heatmap illustrating the particular differential analysis outcomes (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3A</bold>
</xref>) employing the R package. Furthermore, we assessed the extent of group divergence for these 20 pathways across various cohorts from the Combined dataset, utilizing the Mann-Whitney U test, and we use a group comparison plot to illustrate the outcomes (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3B</bold>
</xref>). The findings demonstrated marked differences in pathway expression among disease control cohorts within the Combined dataset.</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Construction of MMRDEGs diagnostic model</title>
<p>Based on the Combined dataset, we examined the expression levels of the 16 MMRDEGs using Random Forest algorithm (RF) to evaluate the values in diagnosis of the 16 MMRDEGs (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). IncNodePurity (Increase in NodePurity) indicates the enhancement in node purity. The higher the node purity, the less impurities it contains (that is, the smaller the Gini coefficient). We applied an IncNodePurity threshold of &gt; 0.5 to filter the specific analysis outcomes. The findings (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>) revealed that 7 diagnostic markers were obtained by RF algorithm. They are: <italic>OCRL</italic>, <italic>GAPDH</italic>, <italic>TPI1</italic>, <italic>LDHA</italic>, <italic>SOD1</italic>, <italic>HK2</italic> and <italic>PGK1</italic>.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Construction of MMRDEGs diagnostic model. <bold>(A)</bold> Plot of model training error of RF algorithm. <bold>(B)</bold> IncNodePurity presentation of MMRDEGs in the RF model (in descending order of IncNodePurity). <bold>(C)</bold> Forest Plot of Logistic regression model for MMRDEGs. <bold>(D)</bold> Diagnostic model plot of LASSO regression model. <bold>(E)</bold> Variable trajectory plot of LASSO regression model. <bold>(F)</bold> Venn diagram of MMRDEGs in LASSO regression model and MMRDEGs in RF model. <bold>(G)</bold> The mRNA expressions of <italic>OCRL</italic>, <italic>GAPDH</italic>, <italic>TPI1</italic> and <italic>LDHA</italic> of placental tissues in the PE cases and Control group. The symbol ** is equivalent to <italic>p &lt; 0.01</italic>, which is highly statistically significant; The symbol **** is equivalent to <italic>p &lt; 0.0001</italic> and is highly statistically significant. PE, Preeclampsia; MMRDEGs, Mitochondrial energy metabolism related differentially expressed genes; LASSO, Least Absolute Shrinkage and Selection Operator; Common MMRDEGs, Common Mitochondrial energy metabolism related differentially expressed genes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1595706-g005.tif">
<alt-text content-type="machine-generated">A composite image includes the following visualizations: A) A line graph showing Random Forest output with error rates decreasing over 1000 trees. B) A dot plot of variable importance by IncNodePurity for various genes. C) A forest plot showing odds ratios for different genes with confidence intervals. D) A plot of binomial deviance against log lambda for model selection, featuring error bars and vertical dashed lines. E) Coefficients plotted against log lambda for various genes. F) A Venn diagram comparing LASSO and Random Forest models with overlapping and unique feature counts. G) Bar graphs show relative mRNA expression levels of OCRL, GAPDH, TPI1, and LDHA, comparing Control and PE groups with statistical significance indicated.</alt-text>
</graphic>
</fig>
<p>Logistic regression was performed utilizing the expression levels of 16 MMRDEGs in the Combined dataset, with the screening criterion of <italic>p&lt;</italic> 0.05 (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). The Logistic regression model included a total of 8 MMRDEGs (<italic>ALDH16A1</italic>, <italic>ATG7</italic>, <italic>BTD</italic>, <italic>GAPDH</italic>, <italic>HK2</italic>, <italic>LDHA</italic>, <italic>OCRL</italic> and <italic>TPI1</italic>), and the diagnostic model was developed by the expression relative quantities of the 8 genes in the combined dataset (the expression levels were evaluated by Least Absolute Shrinkage and Selection Operator (LASSO) analysis). And the findings of the LASSO analysis were illustrated via the LASSO regression model diagram (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>) and the LASSO variable trajectory plot (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5E</bold>
</xref>). The findings indicated that the diagnostic model comprised 6 MMRDEGs, which were: <italic>ALDH16A1</italic>, <italic>ATG7</italic>, <italic>GAPDH</italic>, <italic>LDHA</italic>, <italic>OCRL</italic> and <italic>TPI1</italic>.</p>
<p>Then we interposed the MMRDEGs from the RF model and the MMRDEGs from the Logistic-LASSO regression model (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5F</bold>
</xref>), and 4 Common MMRDEGs (<italic>p &lt; 0.05</italic>) were obtained, which were <italic>OCRL</italic>, <italic>GAPDH</italic>, <italic>TPI1</italic> and <italic>LDHA</italic>.</p>
<p>Next, we examined the differential expression of the 4 Common MMRDEGs in the placental tissues of preeclamptic and normal mothers using RT-qPCR. The demographic characteristics of the PE patients are presented in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;7</bold>
</xref>. The findings indicated that the mRNA expressions of the 4 common genes were notably elevated in the placental tissues of the PE cases relative to the Control group (<italic>p &lt; 0.05</italic>, <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5G</bold>
</xref>). These four Common MMRDEGs (<italic>OCRL, GAPDH, TPI1, and LDHA</italic>) were identified for the first time in a study of PE. This novel discovery offers fresh insights into the role of mitochondrial metabolism in preeclampsia and may establish a foundation for the development of future biomarkers and therapeutic targets.</p>
<p>And then, utilizing the expression level of the four Common MMRDEGs in Combined dataset and corresponding coefficients established by applying LASSO analysis, we obtained the MMRDEGs diagnostic model of 4 Common MMRDEGs.</p>
<mml:math display="block" id="M3">
<mml:mrow>
<mml:mtable>
<mml:mtr>
<mml:mtd>
<mml:mtext>Risk&#xa0;Score&#xa0;</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>41.58006654</mml:mn>
<mml:mo>+</mml:mo>
<mml:mi>O</mml:mi>
<mml:mi>C</mml:mi>
<mml:mi>R</mml:mi>
<mml:mi>L</mml:mi>
<mml:mo>*</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>3.921473316</mml:mn>
<mml:mo>+</mml:mo>
<mml:mi>G</mml:mi>
<mml:mi>A</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>D</mml:mi>
<mml:mi>H</mml:mi>
<mml:mo>*</mml:mo>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>2.021501079</mml:mn>
<mml:mo>+</mml:mo>
<mml:mi>T</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>I</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>*</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>0.275314264</mml:mn>
<mml:mo>+</mml:mo>
<mml:mi>L</mml:mi>
<mml:mi>D</mml:mi>
<mml:mi>H</mml:mi>
<mml:mi>A</mml:mi>
<mml:mo>*</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>0.08998086</mml:mn>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:math>
<p>The diagnostic model for MMRDEGs included four Common MMRDEGs. We used combined logistic regression analysis to process the dataset&#x2019;s expression levels to construct a logistic regression model for MMRDEGs. Additionally, we generated a nomogram depicting the impact of these four common MMRDEGs on the logistic regression model (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>). Our findings revealed that among all variables, <italic>OCRL</italic> exhibited notably superior effectiveness within the MMRDEGs logistic regression model.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Validation of the MMRDEGs diagnostic model. <bold>(A)</bold> Nomogram of Common MMRDEGs in MMRDEGs Logistic regression model. <bold>(B)</bold> Decision curve in Logistic regression model of MMRDEGs. <bold>(C)</bold> ROC curve of MMRDEGs diagnostic model in Combined dataset. <bold>(D)</bold> ROC curve of MMRDEGs diagnostic model in GSE75010. <bold>(E)</bold> Functional similarity analysis results among Common MMRDEGs. ROC, receiver operating characteristic curve; AUC, Area Under the Curve, MMRDEGs, Mitochondrial energy metabolism related differentially expressed genes; Common MMRDEGs, Common Mitochondrial energy metabolism related differentially expressed genes; DCA, Decision Curve Analysis. The closer the AUC in the ROC curve is to 1, the better the diagnostic effect is. When AUC was between 0.5 and 0.7, the accuracy was low. When AUC was 0.7-0.9, it had a certain accuracy. AUC &gt; 0.9 had high accuracy.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1595706-g006.tif">
<alt-text content-type="machine-generated">Diagram with five panels related to data analysis. Panel A displays a nomogram showing points assigned to OCRL, GAPDH, TPI1, and LDHA. Panel B is a decision curve analysis illustrating net benefit across risk thresholds. Panels C and D are ROC curves demonstrating sensitivity and 1-specificity, with high AUC values for risk scores. Panel E shows a bar chart comparing LDHA, TPI1, GAPDH, and OCRL with a reference line at 0.50.</alt-text>
</graphic>
</fig>
<p>The diagnostic model&#x2019;s clinical value was appraised through decision curve analysis (DCA), and the findings were presented in <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>. In the DCA graph, a model&#x2019;s line consistently surpasses those of &#x201c;All negative&#x201d; and &#x201c;All positive&#x201d; within a specific range, greater net benefits can be obtained, indicating a stronger model performance. Our findings demonstrate that our constructed model exhibits considerable accuracy in diagnosing PE.</p>
<p>To further substantiate the value of the MMRDEGs diagnostic model, we drew ROC curves utilizing the Risk Scores of the diagnostic model of MMRDEGs and the information for grouping (PE/Control) of the Combined dataset and displayed the outcomes (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). The MMRDEGs diagnostic model exhibited substantial precision in the diagnosis of the two groups (PE/Control) (AUC = 0.970, CI=0.930-1.000, <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>).</p>
<p>We further validated the diagnostic performance of the MMRDEGs diagnostic model using the GSE75010 dataset. Specifically, we calculated the risk scores by applying the formula derived from the MMRDEGs diagnostic model and the gene expression profiles in GSE75010. Subsequently, we incorporated the grouping information to construct the ROC curve. The results indicated that the MMRDEGs diagnostic model exhibited satisfactory accuracy in distinguishing the PE and Control groups within the GSE75010 dataset (AUC = 0.877, CI 0.823-0.932, <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>).</p>
<p>We also performed functional similarity analysis for four Common MMRDEGs and displayed them using a boxplot. We calculated the semantic similarity of sets of GO terms, GO terms, gene products and gene clusters through the R package GOSemSim. Similarity analysis was performed only on genes that were annotated to pathways in MF, BP, and CC. Finally, functional similarity analysis results between four Common MMRDEGs were obtained and visualized by Boxplot (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6E</bold>
</xref>). The findings indicated that LDHA exhibited the greatest functional similarity score in comparison to other Common MMRDEGs (the X-axis of D graph is the similarity score, with higher values indicating increased functional similarity to other genes).</p>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>GSEA and GSVA based on Combined dataset between the Low and the High-Risk cohorts</title>
<p>Initially, we categorized those disease samples from the Combined dataset into the Low-Risk Score group and the High-Risk Score group utilizing the median Risk-Score of the previous MMRDEGs diagnostic model and performed a differential analysis between the two groups utilizing the limma package (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). Based on the results of the differential analysis, we conducted GSEA to explore the relationship among the MFs, the CCs, the BPs and the expression of all genes involved between the different groups (Low/High Risk-Score group) in the Combined dataset, using the threshold of p &lt; 0.05 for enrichment selection. The findings demonstrated a significant enrichment of genes linked to the citric acid TCA cycle and respiratory electron transport (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>), IL5 signaling pathway (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>), IL7 signaling pathway (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7E</bold>
</xref>), IL6 signaling pathway (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7F</bold>
</xref>), energy metabolism (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7G</bold>
</xref>), electron transport chain Oxphos system in mitochondria (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7H</bold>
</xref>) as well as other pathways, indicating their association with High and Low Risk cohorts (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;8</bold>
</xref>). Furthermore, the GSEA outcomes of genes among the High Risk-Score cohort and the Low Risk-Score cohort in the Combined dataset were presented by mountain plot (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>GSEA enrichment analysis between high and low risk-score groups of Combined dataset. <bold>(A)</bold> Volcano plot of gene difference analysis between High and Low Risk-score groups in Combined dataset. <bold>(B)</bold> Mountain plot display of six main biological characteristics of GSEA enrichment analysis results. C-H. Genes significantly enriched in the citric acid TCA cycle and respiratory electron transport between the High and Low Risk-score groups of Combined dataset <bold>(C)</bold>, IL7 signaling pathway <bold>(D)</bold>, IL5 signaling pathway <bold>(E)</bold>, IL6 pathway <bold>(F)</bold>, energy metabolism <bold>(G)</bold>, electron transport chain Oxphos system in mitochondria <bold>(H)</bold>. PE, Preeclampsia; GSEA, Gene Set Enrichment Analysis. The significant enrichment screening criterion for GSEA enrichment analysis was <italic>p &lt; 0.05</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1595706-g007.tif">
<alt-text content-type="machine-generated">Volcano plot and GSEA results highlighting changes in gene expression. Plot A depicts differential expression with up (blue), down (orange), and not significant (gray) genes. Panel B summarizes pathways with normalized enrichment scores (NES) and P-values. Panels C to H show detailed enrichment plots for specific pathways, including Citric Acid Cycle, IL5, IL7 signaling, and more, with enrichment scores and ranked datasets.</alt-text>
</graphic>
</fig>
<p>To investigate the disparities among the High Risk-Score cohort and the Low Risk-Score cohort in the Combined dataset, we subsequently conducted GSVA. From the pathways with a <italic>p &lt; 0.05</italic>, we identified 10 pathways with the highest and lowest logFC for further analysis (refer to <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;9</bold>
</xref> for detailed information), respectively. The GSVA results of all genes revealed significant differences in 20 pathways among the High and Low Risk-Score cohorts in the Combined dataset. These pathways include defective <italic>CSF2RB</italic> causes <italic>SMDP5, IPS LCP</italic> with <italic>H3K4ME3</italic> and <italic>H3K27ME3</italic>, Korkola choriocarcinoma <italic>DN</italic>, <italic>FGFR3B</italic> ligand binding and activation, Aml methylation Cluster <italic>7 DN</italic>, Turashvili breast carcinoma Ductal vs Lobular <italic>DN</italic>, <italic>FTO</italic> obesity variant mechanism, miscellaneous substrates, <italic>PEPI</italic> pathway, <italic>ES LCP</italic> with <italic>H3K4ME3</italic> and <italic>H3K27ME3</italic> angiogenic targets of <italic>VHL HIF2A</italic> up regulation Biocarta Myosin pathway <italic>OPN</italic> targets Cluster 3 <italic>Myc</italic> targets <italic>DN CTNNB1</italic> pathway and proliferation mesothelioma survival up schavolt targets of <italic>TP53</italic> and <italic>TP63 MAPK11</italic> targets Pujana breast cancer with <italic>BRCA1</italic> mutated <italic>DN</italic> regulation of <italic>PTEN</italic> localization. According to the GSVA outcomes, we analyzed the differential expression of 20 pathways among the Low-Risk cohort and the High-Risk cohort in the Combined dataset, and the specific differential analysis findings (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;4A</bold>
</xref>) was showed as a heatmap by the R package. Furthermore, we employed the Mann-Whitney U test to examine the group distinction level of 20 pathways between diverse cohorts in the Combined dataset and displayed the findings by group comparison plot (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;4B</bold>
</xref>). The findings suggested that all the expressions of the 20 pathways were markedly different among the Low-Risk cohort and High-Risk cohort in the Combined dataset (<italic>p</italic>&lt;0.05).</p>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Analysis of differences in ssGSEA immune characteristics among the Low and High-Risk groups in the Combined dataset</title>
<p>We categorized PE samples in the Combined dataset into the Low Risk-Score and the High Risk-Score cohorts by the median Risk-Score of the MMRDEGs diagnostic model.</p>
<p>To study the difference of immune infiltration between the Low/High Risk-Score groups of the Combined dataset, we applied ssGSEA algorithm to computer the abundance of 28 immune cell infiltration in the two risk-score sample groups. And then, we used Mann-Whitney U test to analyze the differences of the two abundances of the Low and High Risk-Score groups, using group comparison plot to exhibit the results (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). The findings suggested that there were two immune cells, namely Neutrophil and Plasmacytoid Dendritic cell, showing statistically differences in the abundance between the Low and High Risk-Score groups (<italic>p &lt; 0.05</italic>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Differential analysis of ssGSEA immune characteristics between high and low risk-score groups in Combined dataset data. <bold>(A)</bold> The group comparison of ssGSEA immune infiltration analysis between the Low/High Risk-score groups of Combined dataset data. <bold>(B, C)</bold> Scatter plot of correlation between Neutrophil and Plasmacytoid dendritic cell of cell infiltration abundance in the Low Risk-score group <bold>(B)</bold> and High Risk-score group <bold>(C)</bold> of Combined dataset. <bold>(D, E)</bold> Dot plot of correlation between immune cells and Common MMRDEGs in the Low Risk-score group <bold>(D)</bold> and High Risk-score group <bold>(E)</bold> of Combined dataset. ssGSEA, single-sample gene-set enrichment Analysis; Common MMRDEGs, Common Mitochondrial energy metabolism related differentially expressed genes; PE, preeclampsia. The symbol ns is equivalent to <italic>p &#x2265; 0.05</italic> and not statistically significant; The symbol * is equivalent to <italic>p &lt; 0.05</italic>, which is statistically significant; The symbol ** is equivalent to <italic>p &lt; 0.01</italic>, which is highly statistically significant; The absolute value of the correlation coefficient in the scatter plot of correlation was more than 0.8, indicating a strong correlation. Moderate correlation was defined as an absolute value between 0.5 and 0.8. 0.3-0.5 is weak correlation; Values below 0.3 are considered weak or uncorrelated.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1595706-g008.tif">
<alt-text content-type="machine-generated">Panel A shows box plots comparing immune cell infiltration abundance between low and high groups across various cell types, with statistical significance indicated. Panels B and C present scatter plots with linear regression lines, showing the correlation between neutrophil and plasmacytoid dendritic cell abundance, with Spearman coefficients and p-values for low and high groups, respectively. Panels D and E display bubble plots indicating correlation and significance levels of proteins TP1, OCRL, LDHA, and GAPDH with neutrophil and plasmacytoid dendritic cell abundance in low and high groups, respectively.</alt-text>
</graphic>
</fig>
<p>We plotted the correlation scatter plots showing the relationship among Neutrophil and Plasmacytoid Dendritic cells in the Low-Risk cohort (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>) and the High-Risk cohort (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8C</bold>
</xref>) from the Combined dataset. The outcomes showed that, in the Low Risk-Score group, there was a marked inverse association among Neutrophil and Plasmacytoid Dendritic cells (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>, R = -0.709, <italic>p</italic> = 0.028). However, there was no association between the two immune cells in the High Risk-Score group (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8C</bold>
</xref>).</p>
<p>We used Spearman&#x2019;s statistical algorithm to calculate the association between the infiltrating abundances of the Neutrophil, Plasmacytoid Dendritic cells in the Low and High Risk-Score cohorts, and the expression of the four Common MMRDEGs in the Combined dataset data group (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8D, E</bold>
</xref>). The findings suggested that Neutrophil was positively correlated with the four Common MMRDEGs in the Low Risk-Score cohort of the Combined dataset (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8D</bold>
</xref>), moreover Neutrophil and <italic>OCRL</italic> had the strongest association. In the High Risk-Score cohort of the Combined dataset data, Plasmacytoid Dendritic cells had the strongest correlation with <italic>OCRL</italic> (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8E</bold>
</xref>).</p>
</sec>
<sec id="s3_8">
<label>3.8</label>
<title>Cell-type Identification by Estimating Relative Subsets of RNA Transcripts (CIBERSORT) immunosignature comparative analysis among Low Risk-Score and High Risk-Score groups from the Combined dataset</title>
<p>The CIBERSORT method was utilized to estimate the abundance of 22 immune cell infiltrations in both the Low and High Score cohorts. A stacked bar chart was employed to graphically depict the distribution of immune cells across the dataset samples (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;5A</bold>
</xref>). There were 22 immune cells with non-zero infiltration abundances within the Combined dataset according to the results.</p>
<p>We used Spearman&#x2019;s statistical algorithm to assess the relationships among the 22 immune cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;5B</bold>
</xref>), and the findings suggested that the number of positive and negative associations between the 22 immune cells was basically equal, among which Mast cells activated and B cells memory had the strongest correlation.</p>
<p>We subsequently computed the association among immune cells and the four Common MMRDEGs using Spearman&#x2019;s statistical algorithm (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;5C</bold>
</xref>). The results showed that T cells CD4 memory activated, Dendritic cells resting, and T cells gamma delta were moderately positively correlated with the four Common MMRDEGs in the Combined dataset. Among all the associations examined, the most pronounced relationship was detected among na&#xef;ve B cells and <italic>GAPDH</italic>.</p>
</sec>
<sec id="s3_9">
<label>3.9</label>
<title>PPI network and mRNA-RBP, mRNA-Drug and mRNA-TF interaction network were constructed</title>
<p>Since these four Common MMRDEGs (<italic>OCRL, GAPDH, TPI1, LDHA</italic>) are the most potentially valuable biomarker genes identified during model construction, they are suspected to play a crucial role in related disease processes. Therefore, conducting an in-depth study on their interactions can aid in understanding their biological mechanisms and clinical applications. Therefore, we utilized the STRING database (PPI network, minimum required interaction score: low confidence (0.150)) to perform the PPI analysis of the 4 Common MMRDEGs (treated as hub genes) and visualized by Cytoscape software (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9A</bold>
</xref>).</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>Construct PPI network and mRNA-RBP, mRNA-TF, mRNA-Drug interaction network. <bold>(A)</bold> Protein interaction network of Common MMRDEGs (PPI network). <bold>(B)</bold> mRNA-RBP network of Common MMRDEGs, blue quadrangle blocks are mRNA; Green quadrilateral blocks are RBP. <bold>(C)</bold> mRNA-TF network of Common MMRDEGs, and the blue quadrangle blocks in the mRNA-TF interaction network are mRNA; Green quadrangle-shaped blocks are TFs. <bold>(D)</bold> mRNA-Drug network of Common MMRDEGs, and the blue quadrangle blocks in the mRNA-Drug interaction network are mRNA; Green quadrangular blocks are drugs. PE, Preeclampsia; RBP, RNA binding protein; TFs, Transcription factors; Common MMRDEGs, Common Mitochondrial energy metabolism related differentially expressed genes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1595706-g009.tif">
<alt-text content-type="machine-generated">Graph showing four panels (A, B, C, D) illustrating different molecular interactions. Panel A (PPI) features protein-protein interactions among OCRL, GAPDH, LDHA, and TPI1. Panel B (mRNA-RBP) displays mRNA-RBP interactions, with nodes connecting OCRL, GAPDH, LDHA, TPI1 to various RBPs. Panel C (mRNA-TF) shows transcription factor interactions, linking GAPDH to multiple TFs. Panel D (mRNA-Drug) highlights mRNA-Drug interactions, with nodes connecting OCRL, GAPDH, LDHA, TPI1 to various drugs. Each panel has color-coded nodes representing different interaction types.</alt-text>
</graphic>
</fig>
<p>And then, we utilized the ENCORI database to forecast RNA binding proteins (RBPs) that interacted with four Common MMRDEGs and subsequently visualized the mRNA-RBP interaction network by Cytoscape software (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9B</bold>
</xref>). The mRNA-RBP interaction network, in which green quadrilateral blocks presenting RBPs and the blue quadrilateral blocks presenting mRNAs, was composed of 4 Common MMRDEGs (<italic>OCRL</italic>, <italic>GAPDH</italic>, <italic>TPI1</italic> and <italic>LDHA</italic>) and 51 RBP molecules, which constituted 58 pairs of mRNA-RBP interaction relationships. The specific mRNA-RBP interaction relationships are depicted in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;10</bold>
</xref>.</p>
<p>We utilized the CHIPBase database (version 3.0) and hTFtarget database to identify transcription factors (TFs) that bound to the four Common MMRDEGs. Then we screened by &#x201c;Number of samples found (downstream)&gt;0&#x201d; and &#x201c;Number of samples found (upstream) &gt;0&#x201d;, and finally got 3 Common MMRDEGs (<italic>OCRL</italic>, <italic>GAPDH</italic>, <italic>TPI1</italic>) and 39 pairs of interaction data of 29 TFs were graphically represented utilizing Cytoscape software (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9C</bold>
</xref>). In the mRNA-TF interaction network, those blue quadrilateral blocks represent mRNAs, and the green quadrilateral blocks are TFs. The detailed mRNA-TF interactions are depicted in the <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;11</bold>
</xref>.</p>
<p>We employed the Comparative Toxicogenomics Database (CTD) to identify small molecule compounds or potential drugs that interact with four commonly observed MMRDEGs. The selection criterion for mRNA-Drugs interaction pairs was set as &#x201c;Reference Count&#x201d; &gt; 1. To render the mRNA-Drug interaction network (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9D</bold>
</xref>), we employed Cytoscape software. Within the mRNA-Drugs interaction network, the blue quadrilateral blocks signify mRNAs, while the green quadrilateral blocks denote drugs. Our analysis revealed that our mRNA-Drugs interaction network consisted of three common MMRDEGs (<italic>OCRL, LDHA</italic>, and <italic>TPI1</italic>) and twenty-four drug molecules, forming thirty mRNA-Drugs interaction associations. Detailed information regarding these specific interactions can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;12</bold>
</xref>.</p>
<p>The AlphaFold Protein Structure Database (<ext-link ext-link-type="uri" xlink:href="https://www.alphafold.ebi.ac.uk/">https://www.alphafold.ebi.ac.uk/</ext-link>) encompasses approximately 350,000 protein structure predictions generated by the AlphaFold AI system. This comprehensive database includes predictions for humans and 20 widely studied model organisms in biological research, such as E. coli, Drosophila, zebrafish, and mice. Remarkably, AlphaFold has successfully predicted the structures of 98.5% of human proteins within the human proteome. By combining AlphaFold&#x2019;s structural prediction, we can more comprehensively construct and understand complex interaction networks, revealing the important roles of these genes in cellular metabolic regulation. This, in turn, provides a molecular basis for exploring the mechanisms of related diseases. To investigate the protein structures of four common MMRDEGs, we leveraged the resources provided by the AlphaFold website and presented our findings in <xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10A&#x2013;D</bold>
</xref>.</p>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>Protein structures of common MMRDEGs. The protein structures of LDHA <bold>(A)</bold>, GAPDH <bold>(B)</bold>, OCRL <bold>(C)</bold>, and TPI1 <bold>(D)</bold> are shown. The AlphaFold website produced a confidence score per residue (pLDDT) between 0 and 100. Some regions below 50 pLDDT may be isolated unstructured regions, and when pLDDT &lt; 50 (red area), the model confidence is very low; When 50 &lt; pLDDT &lt; 70 (yellow area), the model confidence is low; When 70 &lt; pLDDT &lt; 90 (light blue area), the model confidence was normal. When 90 &lt; pLDDT (blue area), the model confidence is very high. Common MMRDEGs, Common Mitochondrial energy metabolism related differentially expressed genes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1595706-g010.tif">
<alt-text content-type="machine-generated">Four protein structures labeled A to D. A shows the LDHA protein with a complex blue and teal ribbon structure. B displays the GAPDH protein with blue coiled ribbons. C depicts the OCRL protein with an intricate arrangement of blue, teal, yellow, and brown ribbons. D features the TPI1 protein with spiraling blue and teal ribbons. Each protein is represented in a three-dimensional format highlighting their unique configurations.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>PE is a prevalent and severe complication of pregnancy, posing a substantial threat to both maternal and infant health. Its prognosis is intricately linked to maternal and infant outcomes. The primary clinical manifestations include hypertension, proteinuria, as well as liver and kidney impairment (<xref ref-type="bibr" rid="B59">59</xref>). Currently, the precise pathogenesis of PE remains incompletely elucidated. Study indicates that mitochondrial dysfunction is a pivotal factor in the development and progression of PE, with marked mitochondrial abnormalities being detected in PE patient (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B60">60</xref>). The level of oxidative stress in patients with PE is significantly elevated. The excessive production of oxygen free radicals can induce damage to placental trophoblast cells (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B61">61</xref>), while mitochondrial dysfunction further exacerbates oxidative stress, creating a vicious cycle that worsens the progression of PE (<xref ref-type="bibr" rid="B58">58</xref>). Mitochondria are the primary organelles responsible for cellular energy production. Impairment in mitochondrial function leads to a decrease in energy supply, which may contribute to elevated blood pressure, proteinuria, and multi-organ dysfunction among patients diagnosed with PE (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>). In addition, the immune response in patients with PE is markedly enhanced (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B64">64</xref>). Another study suggests that immune system dysregulation may be closely associated with mitochondrial dysfunction (<xref ref-type="bibr" rid="B65">65</xref>), thus implying that immune dysregulation could contribute to the development of PE. Moreover, studies have further demonstrated that PE patients face a significantly elevated risk of developing hypertension and cardiovascular disease later in life (<xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B67">67</xref>). PE can also result in FGRs, intrauterine distress, preterm delivery, and even intrauterine death due to its impact on maternal-fetal blood supply and oxygen delivery (<xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B69">69</xref>). Therefore, the early diagnosis of PE is essential for enabling timely intervention and effectively reducing maternal and infant risks (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B71">71</xref>). Currently, clinical screening primarily relies on the measurement of blood pressure and proteinuria (<xref ref-type="bibr" rid="B72">72</xref>), along with evaluations of edema, liver and kidney function (<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>). However, these methods have limitations in terms of sensitivity and specificity.</p>
<p>Through integrative analysis of the GSE24129, GSE30186, and GSE54618 datasets, we identified 1,073 DEGs between PE cases and Control group. Subsequent comparative intersection analysis with MMRGs revealed 24 MMRDEGs. Notably, 16 of these MMRDEGs demonstrated significant differential expression patterns between PE cases and Control group. These DEGs may be associated with the development of PE, especially those MMRDEGs, which may affect cellular energy production and metabolic processes and play important roles in PE. Mitochondrial energy metabolism is a common metabolic pathway in tumor cells, and MMRDEGs may include key genes for hypoxia, oxidative stress and programmed cell death. Aberrant expression of these genes may lead to impaired chorionic trophoblast cell function, which in turn affects the development and prognosis of PE.</p>
<p>In this investigation, our findings revealed that <italic>ATG7</italic> expression was markedly decreased in PE cases. <italic>ATG7</italic> is an important component of early autophagy that encodes the E1 ubiquitin-activating enzyme, and its absence can lead to defective autophagy in the uterine vascular microenvironment, which in turn reduces uterine vascular permeability (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>). Decreased <italic>ATG7</italic> expression was found to inhibit primary cilia formation and trophoblast invasion, which in turn led to poor pregnancy outcomes (<xref ref-type="bibr" rid="B77">77</xref>). However, we must also acknowledge the dual role of autophagy in both physiological and pathological states, as excessive inhibition of autophagy may similarly have negative impacts on placental function. Alzubaidi et&#xa0;al. discovered that <italic>ATG7</italic> was elevated expressed in placental tissues of PE patients (<xref ref-type="bibr" rid="B78">78</xref>). This contradiction indicates that our current understanding of the relationship between <italic>ATG7</italic> and PE is potentially inadequate. Therefore, it is crucial to clarify the role of <italic>ATG7</italic> in various environments. Future research, particularly longitudinal studies, will be essential to elucidate the precise role of <italic>ATG7</italic> in the pathogenesis of PE. The main function of <italic>SOD1</italic> is to reduce free radical damage to cells through redox reactions. Studies showed that Oxidative stress inhibited SOD1 expression in placental tissue, which was significantly decreased in L-NAME-induced preeclamptic mice (<xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B80">80</xref>) and it align closely with the conclusions drawn in our study. <italic>FOXO1</italic> is a member of the <italic>FOXO</italic> family and is intimately linked to cellular autophagy (<xref ref-type="bibr" rid="B81">81</xref>). It was confirmed that <italic>FOXO1</italic> was highly expressed in placental tissues of PE patients, which is consistent with our findings (<xref ref-type="bibr" rid="B78">78</xref>).</p>
<p>Functional correlation analysis was performed to explore the 16 MMRDEGs, we acquired a series of crucial insights regarding the PE pathogenesis. Firstly, GO analysis findings indicated that these 16 genes were primarily enriched in pyruvate metabolism, glycolysis, and ATP metabolism. Furthermore, KEGG analysis demonstrated that these genes are linked to processes such as glycolysis/glycolysis, HIF-1 signaling pathway, carbon metabolism, inositol phosphate metabolism, alanine, aspartate and glutamate metabolism. It has been established that placental mitochondrial dysfunction is prevalent in preeclampsia, while the inability to upregulate glycolysis is significantly correlated with increased disease severity (<xref ref-type="bibr" rid="B82">82</xref>). Pyruvate, a key product of glycolysis, plays an essential role in the production of reducing equivalents within mitochondria, ATP synthesis, and biosynthesis pathways such as glucose, fatty acids, and amino acids. Pyruvate metabolism is crucial for maintaining carbon homeostasis, and its dysregulation has been linked to various diseases, including diabetes, cancer, Embryogenesis, and cardiovascular disorders (<xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B84">84</xref>). HK-2 exhibits phosphotransferase activity, alcohol-group receptor activity, and fructokinase activity. Relevant pathways include glycolysis and GDP-glucose biosynthesis II. Studies demonstrated that HK-2 is involved in glycolytic flux and mitochondrial activity during maladaptive inflammation in brain diseases. Additionally, HK-2 may exert therapeutic effects in osteoarthritis by modulating glucose metabolism (<xref ref-type="bibr" rid="B85">85</xref>&#x2013;<xref ref-type="bibr" rid="B87">87</xref>). PGK-1, a glycolytic enzyme, is associated with glycolysis and gluconeogenesis pathways. Studies have shown that PGK-1 plays a significant role in neurodegenerative diseases (<xref ref-type="bibr" rid="B88">88</xref>, <xref ref-type="bibr" rid="B89">89</xref>). Various studies have investigated the pivotal role of hypoxia-inducible factor-1 (HIF-1) in metabolic reprogramming across multiple pathways, including glycolysis, glycogen synthesis, lipid metabolism, the electron transport chain (ETC), the tricarboxylic acid (TCA) cycle, glutamine and serine metabolism, ROS production, as well as mitochondrial biogenesis and autophagy (<xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B91">91</xref>). Abnormal expression of DNA and histone proteins represents a key characteristic of tumor cells. Their nucleotide metabolism and epigenetic regulation rely on the one-carbon metabolic pathway to preserve genomic stability and integrity (<xref ref-type="bibr" rid="B92">92</xref>). Given the further potential regulatory functions of mitochondria in abnormal energy metabolism, it offers a novel perspective for investigating the mechanism of preeclampsia. Finally, GSEA and GSVA analyses demonstrated a significant enrichment of genes from different (PE/Control) groups in the Combined dataset, specifically in the vascular smooth muscle contraction pathway, IL9 signaling pathway, Notch signaling pathway, IL2 signaling pathway, IL6/7 signaling pathway, cell surface interactions at the vascular wall. These gene clusters are critically involved in hypertension pathogenesis, immune regulation, inflammatory responses, and redox homeostasis maintenance through interconnected molecular pathways (<xref ref-type="bibr" rid="B93">93</xref>&#x2013;<xref ref-type="bibr" rid="B96">96</xref>). These findings offer valuable insights and directions for further exploration of the pathogenesis of PE.</p>
<p>In the study, we constructed a diagnostic model containing four Common MMRDEGs (<italic>OCRL, GAPDH, TPI1</italic>, <italic>LDHA)</italic>, and verified that the model had high accuracy (AUC = 0.970) by ROC curve. Additionally, an external validation dataset was employed to assess the applicability of the model, and the results showed that the model achieved satisfactory accuracy for diagnosing PE. These four Common MMRDEGs not only showed significant differential expression, but also functional similarity among them. <italic>OCRL</italic> encodes an inositol polyphosphate 5-phosphatase that acts on phosphoinositide, which is a minor component of cell membranes but is a key regulator of intracellular transport (<xref ref-type="bibr" rid="B97">97</xref>, <xref ref-type="bibr" rid="B98">98</xref>). <italic>OCRL</italic> catalyzes the production of the second messenger inositol triphosphate (IP3) and diacylglycerol (DAG) via phosphatidylinositol metabolism, thereby activating calcium release from intracellular stores. Deficiency in <italic>OCRL1</italic> results in mitochondrial calcium overload, ultimately causing mitochondrial dysfunction and apoptosis in T cells (<xref ref-type="bibr" rid="B99">99</xref>). Study shows that DAG mediates diabetic hyperglycemia and its associated complications via the DAG-PKC signaling pathway (<xref ref-type="bibr" rid="B100">100</xref>). In addition, research has demonstrated that the uterine artery endothelium exhibits an adaptive increase in Ca2+/IP3 exchange during pregnancy, however, a capacity that is notably diminished in preeclampsia (<xref ref-type="bibr" rid="B101">101</xref>). Recent studies have shown that <italic>OCRL</italic> plays an important role in cell metabolism, oxidative stress and inflammatory response, which provides new perspectives for understanding its specific effects in PE (<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B102">102</xref>, <xref ref-type="bibr" rid="B103">103</xref>). Drugs that regulate the expression or function of <italic>OCRL</italic> may help restore the normal metabolic state of the placenta and reduce oxidative stress and inflammation, thereby improving the prognosis of PE.</p>
<p>As a glycolytic enzyme, the main function of <italic>GAPDH</italic> is to catalyze the conversion of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate, concomitantly generating ATP. Therefore, <italic>GAPDH</italic> is a critical energy source for cellular metabolism (<xref ref-type="bibr" rid="B104">104</xref>). In addition, <italic>GAPDH</italic> has a variety of non-glycolytic functions. For instance, regulation of RNA export, DNA repair, autophagy and cell death (<xref ref-type="bibr" rid="B105">105</xref>). Dimethyl fumarate exerts its anti-inflammatory effects by inhibiting glycolysis in immune cells through inhibit the catalytic activity of <italic>GAPDH (</italic>
<xref ref-type="bibr" rid="B106">106</xref>). Further functional validation and mechanism research may provide new targets and help for the early diagnosis and treatment of PE. <italic>TPI1</italic> regulates the interconversion between glyceraldehyde-3-phosphate and dihydroxyacetone phosphate during glycolysis and gluconeogenesis, therefore, it is essential in the modulation of energy metabolism. <italic>TPI1</italic> can function as an inhibitor to modulate NK cytotoxicity via the SHP-1-ERK-STAT3 pathway (<xref ref-type="bibr" rid="B107">107</xref>). And the Erk signaling pathway has a direct impact on trophoblast proliferation (<xref ref-type="bibr" rid="B108">108</xref>). In addition, an increasing number of studies indicated that this gene influences glycolysis in target cells via different pathways, such as the METTL5/cMyc/TPI1 pathway, thereby affecting the onset and prognosis of various diseases, including lung cancer, liver cancer, and myopia (<xref ref-type="bibr" rid="B109">109</xref>&#x2013;<xref ref-type="bibr" rid="B111">111</xref>). <italic>LDHA</italic> is widely present in the cytoplasm and can also be expressed in mitochondria and nucleus, which participate in and regulate cellular energy metabolism and have an important impact on cellular function (<xref ref-type="bibr" rid="B112">112</xref>). <italic>LDHA</italic> depletion leads to a reduction in ATP production, consequently diminishing PI3K-AKT-Foxo1 signaling and impairing the redox responses of effector T cells (<xref ref-type="bibr" rid="B113">113</xref>). Yang M et&#xa0;al. showed that glucose transporter 1 plays a critical role in glucose uptake and subsequent metabolic utilization. Knockdown of <italic>GLUT1</italic> reduced glucose uptake and suppressed lactate production by modulating the mRNA expression of <italic>LDHA</italic>, resulting in impairment of blastocyst implantation, trophoblast invasion, and placental development (<xref ref-type="bibr" rid="B114">114</xref>). Furthermore, we validated their expression in placental tissues using RT-qPCR assay. The before mentioned metabolic and immune disorders were found to be consistent with the impaired mitochondrial function, reduced ATP synthesis, and abnormal immune cell function observed in the placenta of patients with PE. These findings present a novel perspective on potential early diagnostic biomarkers for PE. The diagnostic model combined the expression levels of these genes and successfully differentiated between PE and Control group samples, suggesting their potential utility as diagnostic indicators for pregnancy-related hypertensive conditions.</p>
<p>GSEA and GSVA analyses revealed multiple pathways that exhibited marked differences among the Low and High-risk groups in the Combined dataset, encompassing various biological processes such as redox reactions, immune responses, and cell cycle regulation. Significantly enriched or altered genes in these pathways may have different impacts on Low and High-risk cohorts, leading to significant differences in immune status and cellular function between patients at different risk levels. This provides new insights for understanding risk assessment in PE patients and potential targets for future therapeutic strategies. Additionally, it confirmed the biological validity of the MMRDEGs correlation diagnosis model.</p>
<p>Existing research indicates that PE is a complex pregnancy-related disease involving multiple pathological mechanisms, including abnormal immune system responses. There is an increase in biomarkers indicating activation of the terminal complement pathway (<xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B116">116</xref>). Deer et&#xa0;al. emphasized that immune cells such as regulatory T cells, macrophages, natural killer cells, and neutrophils are known to play major causal roles in the pathology of preeclampsia in their review (<xref ref-type="bibr" rid="B117">117</xref>). Aneman et&#xa0;al. further explored the distinct manifestations of the innate immune system in early and late stages of PE, positing that understanding immune cells holds the key to unveiling the pathogenesis of PE (<xref ref-type="bibr" rid="B118">118</xref>). In addition, Nieves et&#xa0;al. explored the impact of autoimmune diseases and infections on PE, highlighting that these factors can significantly exacerbate the condition (<xref ref-type="bibr" rid="B119">119</xref>). Lastly, Luo et&#xa0;al. uncovered immune interference at the maternal-fetal interface in PE via single-cell analysis and discussed HLA-F-mediated immune tolerance (<xref ref-type="bibr" rid="B120">120</xref>). Our study employed the ssGSEA and CIBERSORT algorithms to analyze immune cell infiltration characteristics between High-Risk and Low-Risk groups. Our study suggests that differential expression of neutrophils and plasmacytoid dendritic cells between these two groups, with neutrophils showing a positive correlation with four common MMRDEGs in the Low-Risk group. And among the 22 types of immune cells with non-zero infiltration abundance, Mast cells and B memory cells exhibited the strongest correlation.</p>
<p>Neutrophils constitute a critical component of the innate immune system. They are recruited to sites of infection or damaged tissues via a series of coordinated processes, including rolling, adhesion, spreading, intravascular crawling, transepithelial migration, and chemotaxis-driven tissue infiltration. These functions depend on cytoskeletal reorganization and energy metabolism. Studies indicated that neutrophils possess the ability to adapt to various metabolic pathways, such as metabolic pathways involving glucose, lipids, and amino acids, during inflammation or in response to different disease states (<xref ref-type="bibr" rid="B121">121</xref>, <xref ref-type="bibr" rid="B122">122</xref>). Notably, mitochondria serve as crucial sites for the metabolic processing of these nutrients. Neutrophil extracellular traps (NETs), induced by oxidative stress, represent a critical immune defense mechanism against external bacterial infections (<xref ref-type="bibr" rid="B123">123</xref>). Moreover, NETs enhance mitochondrial stability through the TLR4/PGC1&#x3b1; pathway (<xref ref-type="bibr" rid="B122">122</xref>). Elevated neutrophil levels have been documented in the peripheral blood and subcutaneous fat micro vessels of patients with PE (<xref ref-type="bibr" rid="B124">124</xref>, <xref ref-type="bibr" rid="B125">125</xref>). Furthermore, studies have demonstrated that the activity of neutrophils is influenced by the alteration in the plasma expression levels of MMP-1 and PAF in patients with PE (<xref ref-type="bibr" rid="B124">124</xref>, <xref ref-type="bibr" rid="B126">126</xref>). One experimental study indicated that neutrophils cultured in placental conditioned medium derived from women with PE exhibited significantly greater adherence to endothelial cells compared to those cultured in placental conditioned medium from controls, suggesting that factors influencing neutrophil quantity and function may originate from placental sources (<xref ref-type="bibr" rid="B124">124</xref>). These studies were consistent with the results of our study.</p>
<p>Dendritic cells (DCs) are professional antigen-presenting cells, and plasmacytoid dendritic cells (pDCs) are one subset of DCs. pDCs can secrete substantial amounts of IFN-&#x3b1; and IFN-&#x3b2;, as well as IL-6, IL-8, IL-12, and tumor necrosis factors (TNFs), via the activation of the Toll-like receptor (TLR) 7/9-MyD88-IRF7 pathway (<xref ref-type="bibr" rid="B127">127</xref>). During pregnancy, the primary role of DCs is to present paternal/fetal antigens to regulatory T cells, thereby maintaining immune tolerance at the maternal-fetal interface (<xref ref-type="bibr" rid="B128">128</xref>). Studies have demonstrated that the levels of pDCs in the serum of PE patients are significantly decreased compared to those of normal patients (<xref ref-type="bibr" rid="B129">129</xref>). In addition, research has shown that DCs display diminished responsiveness to stimulation by various TLRs ligands in PE patients compared to those in healthy pregnancy (<xref ref-type="bibr" rid="B130">130</xref>). Moreover, the expression level of TLR3 at the maternal-fetal interface in PE is significantly elevated (<xref ref-type="bibr" rid="B131">131</xref>). The upregulated expression of TLR3 may function as a protective mechanism to counteract the impaired responsiveness of DCs to the stimulation by various TLR ligands. These findings suggest that DC-mediated inflammation is involved in local regulation at the maternal-fetal interface and may plays a crucial role in the pathogenesis and progression of PE. Our immune infiltration analysis demonstrated a significant inverse correlation between neutrophils and pDCs within the low-risk group. Conversely, no such significant correlation was detected in the high-risk group. These results suggest that there is complex immune regulation mediated by neutrophils and pDCs in PE patients, which may play a critical role in its progression.</p>
<p>Immunological alterations constitute a critical component of the etiology of PE, characterized by the presence of autoantibodies, including agonistic autoantibodies against the angiotensin II type 1 receptor (AT1) and so on (<xref ref-type="bibr" rid="B132">132</xref>). Salby et&#xa0;al. identified the proportion of the B cell is elevated in PE patients, because of a significantly diminished expression of programmed cell death protein 1 (PD-1) on CD27+CD24hiCD38hi regulatory B cells (<xref ref-type="bibr" rid="B133">133</xref>). Experimental investigations have confirmed that B2 cells activated by placental ischemia can induce hypertension, activate circulating NK cells, and promote the production of AT1 agonistic autoantibodies in normally pregnant rats (<xref ref-type="bibr" rid="B132">132</xref>). Mast cells are typically activated in response to pathogen invasion, tissue injury, or infection firstly and can release cytokines to regulate the local inflammatory immune reaction (<xref ref-type="bibr" rid="B134">134</xref>). Previous studies have shown that mast cell-derived exosomal miR-181a-5p regulates the viability, migration, and invasion of HTR-8/SVneo cells through the YY1/MMP-9 pathway (<xref ref-type="bibr" rid="B135">135</xref>). And relevant studies have indicated that the average histamine concentration and mast cell density are higher in PE patients (<xref ref-type="bibr" rid="B136">136</xref>). Our analysis of the immune infiltration in non-zero abundance immune cells showed that Mast cells activated and B cells memory had the strongest correlation. Further supporting of the observation was that Mast cells regulate B cell function through secreted cytokines in diseases such as allergic rhinitis and pulmonary hypertension (<xref ref-type="bibr" rid="B137">137</xref>, <xref ref-type="bibr" rid="B138">138</xref>). In addition, antibodies generated by the B cell lineage and cytokines such as interleukin-10 (IL-10) can substantially modulate the function of mast cells. This modulation can, in turn, promote or restrict the development of regulatory B cells via multiple mechanisms (<xref ref-type="bibr" rid="B134">134</xref>). This finding unveils the connection between mitochondrial metabolism and immune cell function, presenting a novel research avenue for future immunotherapy and targeted interventions targeting PE, offering a fresh perspective for its early diagnosis and intervention.</p>
<p>Finally, as the four Common MMRDEGs are the most potentially valuable biomarkers screened by the model constructed and they may play key roles in the pathogenesis of PE, we constructed the PPI, mRNA-Drug, mRNA-RBP and mRNA-TF interaction networks with the four common genes. We identified 51 RBPs genes that could be therapeutic targets for PE by analyzing gene nodes in the network. Then, we utilized the CTD database to forecast potential therapeutic agents or small molecule compounds for PE treatment, identifying 24 drug molecules. Furthermore, we displayed the protein structures of four common MMRDEGs by leveraging the resources of AlphaFold. The results provided molecular basis for exploring the mechanism of PE. However, the potential mechanism and role required more investigation.</p>
<p>However, there are several important limitations to this study that should be considered when interpreting the results. Firstly, the relatively small sample size of the combined dataset (45 total: 19 preeclampsia cases and 26 controls) may limit the generalizability of transcriptomics and machine learning approaches. Therefore, we validated the mRNA-level expression differences of MMRDEGs using RT-qPCR and conducted the external validation of an independent dataset. Additionally, the significant difference in gestational weeks at delivery between the PE group and the Control group, while clinically relevant to PE management, could introduce confounding factors into gene expression analysis. Future studies should focus on large-scale, multi-center cohorts to enhance the robustness and reliability of the findings and their clinical applicability. Furthermore, protein-level validation of these biomarkers and functional investigations using cell lines and animal models are essential to confirm their roles in the pathogenesis of PE and assess their potential as therapeutic targets.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>In this paper, we comprehensively explored the pathogenesis of preeclampsia, constructed a scoring model, analyzed the relationship between MMRDEGs and immune micro-infiltration, and predicted potential therapeutic targets and drug molecules for PE by GO, KEGG, GSEA, and GSVA. Nevertheless, the specific pathogenesis and molecular targets still need to be further verified.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Ethics Committee of the Affiliated Hospital of Qingdao University (Approval No: QYFY WZLL 29434). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>CaL: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Resources, Software, Supervision, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. FL: Formal Analysis, Data curation, Investigation, Software, Visualization, Writing &#x2013; original draft. ChL: Methodology, Writing &#x2013; review &amp; editing. XZ: Methodology, Writing &#x2013; review &amp; editing. QL: Formal Analysis, Writing &#x2013; review &amp; editing. AJ: Resources, Writing &#x2013; review &amp; editing. SZ: Conceptualization, Formal Analysis, Methodology, Resources, Supervision, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research and/or publication of this article.</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="S13" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2025.1595706/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2025.1595706/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ying</surname> <given-names>H</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial quality control alterations and placenta-related disorders</article-title>. <source>Front Physiol</source>. (<year>2024</year>) <volume>15</volume>:<elocation-id>1344951</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphys.2024.1344951</pub-id>, PMID: <pub-id pub-id-type="pmid">38390447</pub-id></citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taglauer</surname> <given-names>ES</given-names>
</name>
<name>
<surname>Fernandez-Gonzalez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Willis</surname> <given-names>GR</given-names>
</name>
<name>
<surname>Reis</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yeung</surname> <given-names>V</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Antenatal mesenchymal stromal cell extracellular vesicle therapy prevents preeclamptic lung injury in mice</article-title>. <source>Am J Respir Cell Mol Biol</source>. (<year>2022</year>) <volume>66</volume>:<fpage>86</fpage>&#x2013;<lpage>95</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1165/rcmb.2021-0307OC</pub-id>, PMID: <pub-id pub-id-type="pmid">34614384</pub-id></citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cipolla</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Biller</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Persistent brain injury after preeclampsia</article-title>. <source>Neurology</source>. (<year>2017</year>) <volume>88</volume>:<page-range>1216&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1212/WNL.0000000000003773</pub-id>, PMID: <pub-id pub-id-type="pmid">28235812</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duffy</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cairns</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Richards-Doran</surname> <given-names>D</given-names>
</name>
<name>
<surname>van 't Hooft</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gale</surname> <given-names>C</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>A core outcome set for pre-eclampsia research: an international consensus development study</article-title>. <source>BJOG: an Int J obstetrics gynaecology</source>. (<year>2020</year>) <volume>127</volume>:<page-range>1516&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/1471-0528.16319</pub-id>, PMID: <pub-id pub-id-type="pmid">32416644</pub-id></citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Nox2 inhibition reduces trophoblast ferroptosis in preeclampsia via the STAT3/GPX4 pathway</article-title>. <source>Life Sci</source>. (<year>2024</year>) <volume>343</volume>:<fpage>122555</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2024.122555</pub-id>, PMID: <pub-id pub-id-type="pmid">38460811</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murugesan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hussey</surname> <given-names>H</given-names>
</name>
<name>
<surname>Saravanakumar</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sinkey</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Sturdivant</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Powell</surname> <given-names>MF</given-names>
</name>
<etal/>
</person-group>. <article-title>Extracellular vesicles from women with severe preeclampsia impair vascular endothelial function</article-title>. <source>Anesth analgesia</source>. (<year>2022</year>) <volume>134</volume>:<page-range>713&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1213/ANE.0000000000005812</pub-id>, PMID: <pub-id pub-id-type="pmid">34871190</pub-id></citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hobson</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Gurusinghe</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>R</given-names>
</name>
<name>
<surname>Alers</surname> <given-names>NO</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Kingdom</surname> <given-names>JC</given-names>
</name>
<etal/>
</person-group>. <article-title>Melatonin improves endothelial function <italic>in vitro</italic> and prolongs pregnancy in women with early-onset preeclampsia</article-title>. <source>J pineal Res</source>. (<year>2018</year>) <volume>65</volume>:<elocation-id>e12508</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jpi.2018.65.issue-3</pub-id>, PMID: <pub-id pub-id-type="pmid">29766570</pub-id></citation></ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvat Mercnik</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schliefsteiner</surname> <given-names>C</given-names>
</name>
<name>
<surname>Sanchez-Duffhues</surname> <given-names>G</given-names>
</name>
<name>
<surname>Wadsack</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>TGF&#x3b2; signalling: a nexus between inflammation, placental health and preeclampsia throughout pregnancy</article-title>. <source>Hum Reprod Update</source>. (<year>2024</year>) <volume>30</volume>:<page-range>442&#x2013;471</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humupd/dmae007</pub-id>, PMID: <pub-id pub-id-type="pmid">38519450</pub-id></citation></ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Overton</surname> <given-names>E</given-names>
</name>
<name>
<surname>Tobes</surname> <given-names>D</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Preeclampsia diagnosis and management</article-title>. <source>Best Pract Res Clin anaesthesiology</source>. (<year>2022</year>) <volume>36</volume>:<page-range>107&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bpa.2022.02.003</pub-id>, PMID: <pub-id pub-id-type="pmid">35659948</pub-id></citation></ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phipps</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Thadhani</surname> <given-names>R</given-names>
</name>
<name>
<surname>Benzing</surname> <given-names>T</given-names>
</name>
<name>
<surname>Karumanchi</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>Pre-eclampsia: pathogenesis, novel diagnostics and therapies</article-title>. <source>Nat Rev Nephrology</source>. (<year>2019</year>) <volume>15</volume>:<page-range>275&#x2013;89</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41581-019-0119-6</pub-id>, PMID: <pub-id pub-id-type="pmid">30792480</pub-id></citation></ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hardy</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kalyanaraman</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells</article-title>. <source>Cancer Commun (London England)</source>. (<year>2024</year>) <volume>44</volume>:<page-range>448&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cac2.12500</pub-id>, PMID: <pub-id pub-id-type="pmid">37930151</pub-id></citation></ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname> <given-names>B</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ji</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Effects of mitochondria on postmortem meat quality: characteristic, isolation, energy metabolism, apoptosis and oxygen consumption</article-title>. <source>Crit Rev Food Sci Nutr</source>. (<year>2023</year>) <volume>64</volume>:<page-range>11239&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10408398.2023.2235435</pub-id>, PMID: <pub-id pub-id-type="pmid">37452658</pub-id></citation></ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gomez</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kellum</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Mitochondria ROS and mitophagy in acute kidney injury</article-title>. <source>Autophagy</source>. (<year>2023</year>) <volume>19</volume>:<page-range>401&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15548627.2022.2084862</pub-id>, PMID: <pub-id pub-id-type="pmid">35678504</pub-id></citation></ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haridevamuthu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Murugan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Seenivasan</surname> <given-names>B</given-names>
</name>
<name>
<surname>Meenatchi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Pachaiappan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Almutairi</surname> <given-names>BO</given-names>
</name>
<etal/>
</person-group>. <article-title>Synthetic azo-dye, Tartrazine induces neurodevelopmental toxicity via mitochondria-mediated apoptosis in zebrafish embryos</article-title>. <source>J hazardous materials</source>. (<year>2024</year>) <volume>461</volume>:<fpage>132524</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jhazmat.2023.132524</pub-id>, PMID: <pub-id pub-id-type="pmid">37741213</pub-id></citation></ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Su</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Pandey</surname> <given-names>NK</given-names>
</name>
<name>
<surname>Amador</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Combination of disulfiram and Copper-Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer</article-title>. <source>Bioactive materials</source>. (<year>2024</year>) <volume>36</volume>:<fpage>96</fpage>&#x2013;<lpage>111</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bioactmat.2024.02.009</pub-id>, PMID: <pub-id pub-id-type="pmid">38440322</pub-id></citation></ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ticiani</surname> <given-names>E</given-names>
</name>
<name>
<surname>Gingrich</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Vettathu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>J</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Bisphenol S and epidermal growth factor receptor signaling in human placental cytotrophoblasts</article-title>. <source>Environ Health perspectives</source>. (<year>2021</year>) <volume>129</volume>:<fpage>27005</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1289/EHP7297</pub-id>, PMID: <pub-id pub-id-type="pmid">33605785</pub-id></citation></ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Quan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>S</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>PPAR&#x3b3; Regulates triclosan induced placental dysfunction</article-title>. <source>Cells</source>. (<year>2021</year>) <volume>11</volume>:<fpage>86</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells11010086</pub-id>, PMID: <pub-id pub-id-type="pmid">35011648</pub-id></citation></ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>F</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification and verification of diagnostic biomarkers based on mitochondria-related genes related to immune microenvironment for preeclampsia using machine learning algorithms</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1304165</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1304165</pub-id>, PMID: <pub-id pub-id-type="pmid">38259465</pub-id></citation></ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Vanderpeet</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Bartho</surname> <given-names>LA</given-names>
</name>
<name>
<surname>McKeating</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Cuffe</surname> <given-names>JSM</given-names>
</name>
<name>
<surname>Holland</surname> <given-names>OJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial dysfunction in placental trophoblast cells experiencing gestational diabetes mellitus</article-title>. <source>J Physiol</source>. (<year>2021</year>) <volume>599</volume>:<page-range>1291&#x2013;305</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1113/tjp.v599.4</pub-id>, PMID: <pub-id pub-id-type="pmid">33135816</pub-id></citation></ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Juan-Reyes</surname> <given-names>SS</given-names>
</name>
<name>
<surname>G&#xf3;mez-Oliv&#xe1;n</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Juan-Reyes</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Islas-Flores</surname> <given-names>H</given-names>
</name>
<name>
<surname>Dubl&#xe1;n-Garc&#xed;a</surname> <given-names>O</given-names>
</name>
<name>
<surname>Orozco-Hern&#xe1;ndez</surname> <given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Women with preeclampsia exposed to air pollution during pregnancy: Relationship between oxidative stress and neonatal disease - Pilot study</article-title>. <source>Sci total environment</source>. (<year>2023</year>) <volume>871</volume>:<fpage>161858</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.scitotenv.2023.161858</pub-id>, PMID: <pub-id pub-id-type="pmid">36716872</pub-id></citation></ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cipolla</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Tremble</surname> <given-names>SM</given-names>
</name>
<name>
<surname>DeLance</surname> <given-names>N</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>AC</given-names>
</name>
</person-group>. <article-title>Worsened stroke outcome in a model of preeclampsia is associated with poor collateral flow and oxidative stress</article-title>. <source>Stroke</source>. (<year>2023</year>) <volume>54</volume>:<page-range>354&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/STROKEAHA.122.041637</pub-id>, PMID: <pub-id pub-id-type="pmid">36689585</pub-id></citation></ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname> <given-names>J</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Shan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondria targeted antioxidant significantly alleviates preeclampsia caused by 11&#x3b2;-HSD2 dysfunction via OPA1 and mtDNA maintenance</article-title>. <source>Antioxidants (Basel Switzerland)</source>. (<year>2022</year>) <volume>11</volume>:<fpage>1505</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox11081505</pub-id>, PMID: <pub-id pub-id-type="pmid">36009224</pub-id></citation></ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pearce</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Rebelo-Guiomar</surname> <given-names>P</given-names>
</name>
<name>
<surname>D'Souza</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Powell</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Haute</surname> <given-names>LV</given-names>
</name>
<name>
<surname>Minczuk</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Regulation of mammalian mitochondrial gene expression: recent advances</article-title>. <source>Trends Biochem Sci</source>. (<year>2017</year>) <volume>42</volume>:<page-range>625&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tibs.2017.02.003</pub-id>, PMID: <pub-id pub-id-type="pmid">28285835</pub-id></citation></ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ricci</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Reid</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<name>
<surname>Santillan</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Santillan</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Phillips</surname> <given-names>NR</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal and fetal mitochondrial gene dysregulation in hypertensive disorders of pregnancy</article-title>. <source>Physiol Genomics</source>. (<year>2023</year>) <volume>55</volume>:<page-range>275&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/physiolgenomics.00005.2023</pub-id>, PMID: <pub-id pub-id-type="pmid">37184228</pub-id></citation></ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandey</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yevale</surname> <given-names>A</given-names>
</name>
<name>
<surname>Naha</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kuthethur</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chakrabarty</surname> <given-names>S</given-names>
</name>
<name>
<surname>Satyamoorthy</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Mitochondrial DNA copy number variation - A potential biomarker for early onset preeclampsia</article-title>. <source>Pregnancy hypertension</source>. (<year>2021</year>) <volume>23</volume>:<fpage>1</fpage>&#x2013;<lpage>4</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.preghy.2020.10.002</pub-id>, PMID: <pub-id pub-id-type="pmid">33160129</pub-id></citation></ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>EH</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>GZ</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>ZL</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>QQ</given-names>
</name>
</person-group>. <article-title>GRB10 and E2F3 as diagnostic markers of osteoarthritis and their correlation with immune infiltration</article-title>. <source>Diagnostics (Basel)</source>. (<year>2020</year>) <volume>10</volume>:<fpage>171</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/diagnostics10030171</pub-id>, PMID: <pub-id pub-id-type="pmid">32235747</pub-id></citation></ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunk</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Bucher</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hayder</surname> <given-names>H</given-names>
</name>
<name>
<surname>Geraghty</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Lye</surname> <given-names>SJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Human leukocyte antigen HLA-C, HLA-G, HLA-F, and HLA-E placental profiles are altered in early severe preeclampsia and preterm birth with chorioamnionitis</article-title>. <source>Am J Obstetrics Gynecology</source>. (<year>2022</year>) <volume>227</volume>:<fpage>641.e641</fpage>&#x2013;<lpage>641.e613</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajog.2022.07.021</pub-id>, PMID: <pub-id pub-id-type="pmid">35863458</pub-id></citation></ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Du</surname> <given-names>N</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Immune checkpoint molecules on T cell subsets of pregnancies with preeclampsia and gestational diabetes mellitus</article-title>. <source>J Reprod Immunol</source>. (<year>2020</year>) <volume>142</volume>:<fpage>103208</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jri.2020.103208</pub-id>, PMID: <pub-id pub-id-type="pmid">33002799</pub-id></citation></ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>Preeclampsia epidemiology(ies) and pathophysiology(ies)</article-title>. <source>Best Pract Res Clin Obstetrics Gynaecology</source>. (<year>2024</year>) <volume>94</volume>:<fpage>102480</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bpobgyn.2024.102480</pub-id>, PMID: <pub-id pub-id-type="pmid">38490067</pub-id></citation></ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duckitt</surname> <given-names>K</given-names>
</name>
<name>
<surname>Harrington</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies</article-title>. <source>Bmj</source>. (<year>2005</year>) <volume>330</volume>:<fpage>565</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmj.38380.674340.E0</pub-id>, PMID: <pub-id pub-id-type="pmid">15743856</pub-id></citation></ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishizawa</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ota</surname> <given-names>S</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kato</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sekiya</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kurahashi</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction</article-title>. <source>Reprod Biol Endocrinol</source>. (<year>2011</year>) <volume>9</volume>:<fpage>107</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1477-7827-9-107</pub-id>, PMID: <pub-id pub-id-type="pmid">21810232</pub-id></citation></ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname> <given-names>T</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>G</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Identification of differential gene expression profiles in placentas from preeclamptic pregnancies versus normal pregnancies by DNA microarrays</article-title>. <source>Omics: J Integr Biol</source>. (<year>2012</year>) <volume>16</volume>:<page-range>301&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/omi.2011.0066</pub-id>, PMID: <pub-id pub-id-type="pmid">22702245</pub-id></citation></ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jebbink</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Boot</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Keijser</surname> <given-names>R</given-names>
</name>
<name>
<surname>Moerland</surname> <given-names>PD</given-names>
</name>
<name>
<surname>Aten</surname> <given-names>J</given-names>
</name>
<name>
<surname>Veenboer</surname> <given-names>GJM</given-names>
</name>
<etal/>
</person-group>. <article-title>Increased glucocerebrosidase expression and activity in preeclamptic placenta</article-title>. <source>Placenta</source>. (<year>2015</year>) <volume>36</volume>:<page-range>160&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.placenta.2014.12.001</pub-id>, PMID: <pub-id pub-id-type="pmid">25552189</pub-id></citation></ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibbs</surname> <given-names>I</given-names>
</name>
<name>
<surname>Leavey</surname> <given-names>K</given-names>
</name>
<name>
<surname>Benton</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Grynspan</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bainbridge</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Cox</surname> <given-names>BJ</given-names>
</name>
</person-group>. <article-title>Placental transcriptional and histologic subtypes of normotensive fetal growth restriction are comparable to preeclampsia</article-title>. <source>Am J Obstetrics Gynecology</source>. (<year>2018</year>) <volume>220</volume>:<page-range>110.e1&#x2013;110.e21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajog.2018.10.003</pub-id>, PMID: <pub-id pub-id-type="pmid">30312585</pub-id></citation></ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrett</surname> <given-names>T</given-names>
</name>
<name>
<surname>Troup</surname> <given-names>DB</given-names>
</name>
<name>
<surname>Wilhite</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Ledoux</surname> <given-names>P</given-names>
</name>
<name>
<surname>Rudnev</surname> <given-names>D</given-names>
</name>
<name>
<surname>Evangelista</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>NCBI GEO: mining tens of millions of expression profiles&#x2013;database and tools update</article-title>. <source>Nucleic Acids Res</source>. (<year>2007</year>) <volume>35</volume>:<page-range>D760&#x2013;765</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkl887</pub-id>, PMID: <pub-id pub-id-type="pmid">17099226</pub-id></citation></ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname> <given-names>S</given-names>
</name>
<name>
<surname>Meltzer</surname> <given-names>PS</given-names>
</name>
</person-group>. <article-title>GEOquery: a bridge between the gene expression omnibus (GEO) and bioConductor</article-title>. <source>Bioinf (Oxford England)</source>. (<year>2007</year>) <volume>23</volume>:<page-range>1846&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btm254</pub-id>, PMID: <pub-id pub-id-type="pmid">17496320</pub-id></citation></ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stelzer</surname> <given-names>G</given-names>
</name>
<name>
<surname>Rosen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Plaschkes</surname> <given-names>I</given-names>
</name>
<name>
<surname>Zimmerman</surname> <given-names>S</given-names>
</name>
<name>
<surname>Twik</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fishilevich</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>The geneCards suite: from gene data mining to disease genome sequence analyses</article-title>. <source>Curr Protoc Bioinf</source>. (<year>2016</year>) <volume>54</volume>:<fpage>1.30.31</fpage>&#x2013;<lpage>31.30.33</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/0471250953.2016.54.issue-1</pub-id>
</citation></ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>F</given-names>
</name>
<name>
<surname>Lan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Comprehensive analysis of alteration landscape and its clinical significance of mitochondrial energy metabolism pathway-related genes in lung cancers</article-title>. <source>Oxid Med Cell Longev</source>. (<year>2021</year>) <volume>2021</volume>:<fpage>9259297</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2021/9259297</pub-id>, PMID: <pub-id pub-id-type="pmid">34970420</pub-id></citation></ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leek</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>WE</given-names>
</name>
<name>
<surname>Parker</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Jaffe</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Storey</surname> <given-names>JD</given-names>
</name>
</person-group>. <article-title>The sva package for removing batch effects and other unwanted variation in high-throughput experiments</article-title>. <source>Bioinformatics</source>. (<year>2012</year>) <volume>28</volume>:<page-range>882&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/bts034</pub-id>, PMID: <pub-id pub-id-type="pmid">22257669</pub-id></citation></ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Comprehensive Analysis of angiogenesis associated genes and tumor microenvironment infiltration characterization in cervical cancer</article-title>. <source>Heliyon</source>. (<year>2024</year>) <volume>10</volume>:<elocation-id>e33277</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e33277</pub-id>, PMID: <pub-id pub-id-type="pmid">39021997</pub-id></citation></ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Gene ontology semantic similarity analysis using GOSemSim</article-title>. <source>Methods Mol Biol (Clifton NJ)</source>. (<year>2020</year>) <volume>2117</volume>:<page-range>207&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-0716-0301-7_11</pub-id>, PMID: <pub-id pub-id-type="pmid">31960380</pub-id></citation></ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanehisa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Goto</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title>. <source>Nucleic Acids Res</source>. (<year>2000</year>) <volume>28</volume>:<fpage>27</fpage>&#x2013;<lpage>30</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id>, PMID: <pub-id pub-id-type="pmid">10592173</pub-id></citation></ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>LG</given-names>
</name>
<name>
<surname>Han</surname> <given-names>Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>QY</given-names>
</name>
</person-group>. <article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title>. <source>Omics: J Integr Biol</source>. (<year>2012</year>) <volume>16</volume>:<page-range>284&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id>, PMID: <pub-id pub-id-type="pmid">22455463</pub-id></citation></ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tamayo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mootha</surname> <given-names>VK</given-names>
</name>
<name>
<surname>Mukherjee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ebert</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Gillette</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci United States America</source>. (<year>2005</year>) <volume>102</volume>:<page-range>15545&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>, PMID: <pub-id pub-id-type="pmid">16199517</pub-id></citation></ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liberzon</surname> <given-names>A</given-names>
</name>
<name>
<surname>Subramanian</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pinchback</surname> <given-names>R</given-names>
</name>
<name>
<surname>Thorvaldsd&#xf3;ttir</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tamayo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mesirov</surname> <given-names>JP</given-names>
</name>
</person-group>. <article-title>Molecular signatures database (MSigDB) 3</article-title>. <source>0 Bioinf</source>. (<year>2011</year>) <volume>27</volume>:<page-range>1739&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btr260</pub-id>, PMID: <pub-id pub-id-type="pmid">21546393</pub-id></citation></ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xe4;nzelmann</surname> <given-names>S</given-names>
</name>
<name>
<surname>Castelo</surname> <given-names>R</given-names>
</name>
<name>
<surname>Guinney</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>GSVA: gene set variation analysis for microarray and RNA-seq data</article-title>. <source>BMC Bioinf</source>. (<year>2013</year>) <volume>14</volume>:<fpage>7</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2105-14-7</pub-id>, PMID: <pub-id pub-id-type="pmid">23323831</pub-id></citation></ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Variable importance-weighted random forests</article-title>. <source>Quantitative Biol (Beijing China)</source>. (<year>2017</year>) <volume>5</volume>:<page-range>338&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40484-017-0121-6</pub-id>
</citation></ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engebretsen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bohlin</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Statistical predictions with glmnet</article-title>. <source>Clin epigenetics</source>. (<year>2019</year>) <volume>11</volume>:<fpage>123</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13148-019-0730-1</pub-id>, PMID: <pub-id pub-id-type="pmid">31443682</pub-id></citation></ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>SY</given-names>
</name>
</person-group>. <article-title>Nomogram: An analogue tool to deliver digital knowledge</article-title>. <source>J Thorac Cardiovasc surgery</source>. (<year>2018</year>) <volume>155</volume>:<fpage>1793</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jtcvs.2017.12.107</pub-id>, PMID: <pub-id pub-id-type="pmid">29370910</pub-id></citation></ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tataranni</surname> <given-names>T</given-names>
</name>
<name>
<surname>Piccoli</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Dichloroacetate (DCA) and cancer: an overview towards clinical applications</article-title>. <source>Oxid Med Cell longevity</source>. (<year>2019</year>) <volume>2019</volume>:<fpage>8201079</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2019/8201079</pub-id>, PMID: <pub-id pub-id-type="pmid">31827705</pub-id></citation></ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charoentong</surname> <given-names>P</given-names>
</name>
<name>
<surname>Finotello</surname> <given-names>F</given-names>
</name>
<name>
<surname>Angelova</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mayer</surname> <given-names>C</given-names>
</name>
<name>
<surname>Efremova</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rieder</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade</article-title>. <source>Cell Rep</source>. (<year>2017</year>) <volume>18</volume>:<page-range>248&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2016.12.019</pub-id>, PMID: <pub-id pub-id-type="pmid">28052254</pub-id></citation></ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbie</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Tamayo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Boehm</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Moody</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Dunn</surname> <given-names>IF</given-names>
</name>
<etal/>
</person-group>. <article-title>Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1</article-title>. <source>Nature</source>. (<year>2009</year>) <volume>462</volume>:<page-range>108&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature08460</pub-id>, PMID: <pub-id pub-id-type="pmid">19847166</pub-id></citation></ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Khodadoust</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Newman</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Alizadeh</surname> <given-names>AA</given-names>
</name>
</person-group>. <article-title>Profiling tumor infiltrating immune cells with CIBERSORT</article-title>. <source>Methods Mol Biol (Clifton NJ)</source>. (<year>2018</year>) <volume>1711</volume>:<page-range>243&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-4939-7493-1_12</pub-id>, PMID: <pub-id pub-id-type="pmid">29344893</pub-id></citation></ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>von Mering</surname> <given-names>C</given-names>
</name>
<name>
<surname>Huynen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jaeggi</surname> <given-names>D</given-names>
</name>
<name>
<surname>Schmidt</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bork</surname> <given-names>P</given-names>
</name>
<name>
<surname>Snel</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>STRING: a database of predicted functional associations between proteins</article-title>. <source>Nucleic Acids Res</source>. (<year>2003</year>) <volume>31</volume>:<page-range>258&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkg034</pub-id>, PMID: <pub-id pub-id-type="pmid">12519996</pub-id></citation></ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>LH</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data</article-title>. <source>Nucleic Acids Res</source>. (<year>2014</year>) <volume>42</volume>:<page-range>D92&#x2013;97</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkt1248</pub-id>, PMID: <pub-id pub-id-type="pmid">24297251</pub-id></citation></ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Miao</surname> <given-names>YR</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>hTFtarget: A comprehensive database for regulations of human transcription factors and their targets</article-title>. <source>Genomics Proteomics Bioinf</source>. (<year>2020</year>) <volume>18</volume>:<page-range>120&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.gpb.2019.09.006</pub-id>, PMID: <pub-id pub-id-type="pmid">32858223</pub-id></citation></ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torbergsen</surname> <given-names>T</given-names>
</name>
<name>
<surname>&#xf8;ian</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mathiesen</surname> <given-names>E</given-names>
</name>
<name>
<surname>Borud</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Pre-eclampsia-A mitochondrial disease</article-title>? <source>Acta Obstetricia Gynecologica Scandinavica</source>. (<year>1989</year>) <volume>68</volume>:<page-range>145&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/00016348909009902</pub-id>, PMID: <pub-id pub-id-type="pmid">2589041</pub-id></citation></ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mar&#xed;n</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chiarello</surname> <given-names>DI</given-names>
</name>
<name>
<surname>Abad</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rojas</surname> <given-names>D</given-names>
</name>
<name>
<surname>Toledo</surname> <given-names>F</given-names>
</name>
<name>
<surname>Sobrevia</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia</article-title>. <source>Biochim Biophys Acta Mol Basis Dis</source>. (<year>2020</year>) <volume>1866</volume>:<fpage>165961</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbadis.2020.165961</pub-id>, PMID: <pub-id pub-id-type="pmid">32916282</pub-id></citation></ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dimitriadis</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rolnik</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>W</given-names>
</name>
<name>
<surname>Estrada-Gutierrez</surname> <given-names>J</given-names>
</name>
<name>
<surname>Koga</surname> <given-names>K</given-names>
</name>
<name>
<surname>Francisco</surname> <given-names>RPV</given-names>
</name>
<etal/>
</person-group>. <article-title>Pre-eclampsia</article-title>. <source>Nat Rev Dis primers</source>. (<year>2023</year>) <volume>9</volume>:<fpage>8</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41572-023-00417-6</pub-id>, PMID: <pub-id pub-id-type="pmid">36797292</pub-id></citation></ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yung</surname> <given-names>HW</given-names>
</name>
<name>
<surname>Colleoni</surname> <given-names>F</given-names>
</name>
<name>
<surname>Dommett</surname> <given-names>E</given-names>
</name>
<name>
<surname>Cindrova-Davies</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kingdom</surname> <given-names>J</given-names>
</name>
<name>
<surname>Murray</surname> <given-names>AJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Noncanonical mitochondrial unfolded protein response impairs placental oxidative phosphorylation in early-onset preeclampsia</article-title>. <source>Proc Natl Acad Sci United States America</source>. (<year>2019</year>) <volume>116</volume>:<page-range>18109&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1907548116</pub-id>, PMID: <pub-id pub-id-type="pmid">31439814</pub-id></citation></ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiarello</surname> <given-names>DI</given-names>
</name>
<name>
<surname>Abad</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rojas</surname> <given-names>D</given-names>
</name>
<name>
<surname>Toledo</surname> <given-names>F</given-names>
</name>
<name>
<surname>V&#xe1;zquez</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Mate</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Oxidative stress: Normal pregnancy versus preeclampsia</article-title>. <source>Biochim Biophys Acta Mol Basis Dis</source>. (<year>2020</year>) <volume>1866</volume>:<fpage>165354</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbadis.2018.12.005</pub-id>, PMID: <pub-id pub-id-type="pmid">30590104</pub-id></citation></ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Hypoxia and the integrated stress response promote pulmonary hypertension and preeclampsia: Implications in drug development</article-title>. <source>Drug Discov Today</source>. (<year>2021</year>) <volume>26</volume>:<page-range>2754&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.drudis.2021.07.011</pub-id>, PMID: <pub-id pub-id-type="pmid">34302972</pub-id></citation></ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>An</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>B</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Perfluorooctane sulfonate exposure induces preeclampsia-like syndromes by damaging trophoblast mitochondria in pregnant mice</article-title>. <source>Ecotoxicology Environ safety</source>. (<year>2022</year>) <volume>247</volume>:<fpage>114256</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ecoenv.2022.114256</pub-id>, PMID: <pub-id pub-id-type="pmid">36327784</pub-id></citation></ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>A galectin-9-driven CD11c(high) decidual macrophage subset suppresses uterine vascular remodeling in preeclampsia</article-title>. <source>Circulation</source>. (<year>2024</year>) <volume>149</volume>:<page-range>1670&#x2013;88</page-range>. doi:&#xa0;10.1161, PMID: <pub-id pub-id-type="pmid">38314577</pub-id></citation></ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iborra-Pernichi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ruiz Garc&#xed;a</surname> <given-names>J</given-names>
</name>
<name>
<surname>Velasco de la Esperanza</surname> <given-names>M</given-names>
</name>
<name>
<surname>Estrada</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Bovolenta</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Cifuentes</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Defective mitochondria remodelling in B cells leads to an aged immune response</article-title>. <source>Nat Commun</source>. (<year>2024</year>) <volume>15</volume>:<fpage>2569</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-024-46763-1</pub-id>, PMID: <pub-id pub-id-type="pmid">38519473</pub-id></citation></ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olivera</surname> <given-names>S</given-names>
</name>
<name>
<surname>Graham</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Modelling pre-eclampsia and its cardiovascular effects</article-title>. <source>Nat Rev Cardiol</source>. (<year>2024</year>) <volume>21</volume>:<fpage>281</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41569-024-01006-0</pub-id>, PMID: <pub-id pub-id-type="pmid">38480793</pub-id></citation></ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Baker</surname> <given-names>PN</given-names>
</name>
<name>
<surname>Granger</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Davidge</surname> <given-names>ST</given-names>
</name>
<name>
<surname>Tong</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Long-term impacts of preeclampsia on the cardiovascular system of mother and offspring</article-title>. <source>Hypertension</source>. (<year>2023</year>) <volume>80</volume>:<page-range>1821&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.123.21061</pub-id>, PMID: <pub-id pub-id-type="pmid">37377011</pub-id></citation></ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stubert</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hinz</surname> <given-names>B</given-names>
</name>
<name>
<surname>Berger</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>The role of acetylsalicylic acid in the prevention of pre-eclampsia, fetal growth restriction, and preterm birth</article-title>. <source>Deutsches Arzteblatt Int</source>. (<year>2023</year>) <volume>120</volume>:<page-range>617&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3238/arztebl.m2023.0133</pub-id>, PMID: <pub-id pub-id-type="pmid">37378599</pub-id></citation></ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cluver</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Bergman</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bergkvist</surname> <given-names>J</given-names>
</name>
<name>
<surname>Imberg</surname> <given-names>H</given-names>
</name>
<name>
<surname>Geerts</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>DR</given-names>
</name>
<etal/>
</person-group>. <article-title>Impact of fetal growth restriction on pregnancy outcome in women undergoing expectant management for preterm pre-eclampsia</article-title>. <source>Ultrasound obstetrics gynecology: Off J Int Soc Ultrasound Obstetrics Gynecology</source>. (<year>2023</year>) <volume>62</volume>:<page-range>660&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/uog.26282</pub-id>, PMID: <pub-id pub-id-type="pmid">37289938</pub-id></citation></ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benzing</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Hypertension: Testing for pre-eclampsia: paving the way to early diagnosis</article-title>. <source>Nat Rev Nephrology</source>. (<year>2016</year>) <volume>12</volume>:<page-range>200&#x2013;2</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrneph.2016.21</pub-id>, PMID: <pub-id pub-id-type="pmid">26923207</pub-id></citation></ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudhary</surname> <given-names>RK</given-names>
</name>
<name>
<surname>Madaboosi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Satija</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nandagopal</surname> <given-names>B</given-names>
</name>
<name>
<surname>Srinivasan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sai</surname> <given-names>VVR</given-names>
</name>
</person-group>. <article-title>Polymeric optical fiber biosensor with PAMAM dendrimer-based surface modification and PlGF detection for pre-eclampsia diagnosis</article-title>. <source>Biosensors bioelectronics</source>. (<year>2024</year>) <volume>257</volume>:<fpage>116312</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bios.2024.116312</pub-id>, PMID: <pub-id pub-id-type="pmid">38657380</pub-id></citation></ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wright</surname> <given-names>A</given-names>
</name>
<name>
<surname>von Dadelszen</surname> <given-names>P</given-names>
</name>
<name>
<surname>Magee</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Syngelaki</surname> <given-names>A</given-names>
</name>
<name>
<surname>Akolekar</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wright</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of race on the measurement of angiogenic factors for prediction and diagnosis of pre-eclampsia</article-title>. <source>BJOG: an Int J obstetrics gynaecology</source>. (<year>2023</year>) <volume>130</volume>:<fpage>78</fpage>&#x2013;<lpage>87</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/1471-0528.17296</pub-id>, PMID: <pub-id pub-id-type="pmid">36168103</pub-id></citation></ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andronikidi</surname> <given-names>PE</given-names>
</name>
<name>
<surname>Orovou</surname> <given-names>E</given-names>
</name>
<name>
<surname>Mavrigiannaki</surname> <given-names>E</given-names>
</name>
<name>
<surname>Athanasiadou</surname> <given-names>V</given-names>
</name>
<name>
<surname>Tzitiridou-Chatzopoulou</surname> <given-names>M</given-names>
</name>
<name>
<surname>Iatrakis</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Placental and renal pathways underlying pre-eclampsia</article-title>. <source>Int J Mol Sci</source>. (<year>2024</year>) <volume>25</volume>:<fpage>2741</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms25052741</pub-id>, PMID: <pub-id pub-id-type="pmid">38473987</pub-id></citation></ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmadian</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rahbar Saadat</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hosseiniyan Khatibi</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Nariman-Saleh-Fam</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Bastami</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zununi Vahed</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Pre-Eclampsia: Microbiota possibly playing a role</article-title>. <source>Pharmacol Res</source>. (<year>2020</year>) <volume>155</volume>:<fpage>104692</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2020.104692</pub-id>, PMID: <pub-id pub-id-type="pmid">32070720</pub-id></citation></ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>B</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Park</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Jun</surname> <given-names>JH</given-names>
</name>
<etal/>
</person-group>. <article-title>An autophagic deficit in the uterine vessel microenvironment provokes hyperpermeability through deregulated VEGFA, NOS1, and CTNNB1</article-title>. <source>Autophagy</source>. (<year>2021</year>) <volume>17</volume>:<page-range>1649&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15548627.2020.1778292</pub-id>, PMID: <pub-id pub-id-type="pmid">32579471</pub-id></citation></ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakashima</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Ikawa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yoshimori</surname> <given-names>T</given-names>
</name>
<name>
<surname>Huber</surname> <given-names>J</given-names>
</name>
<name>
<surname>Menon</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Evidence for lysosomal biogenesis proteome defect and impaired autophagy in preeclampsia</article-title>. <source>Autophagy</source>. (<year>2020</year>) <volume>16</volume>:<page-range>1771&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15548627.2019.1707494</pub-id>, PMID: <pub-id pub-id-type="pmid">31856641</pub-id></citation></ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Chao</surname> <given-names>YY</given-names>
</name>
<name>
<surname>Su</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Tsai</surname> <given-names>HL</given-names>
</name>
<name>
<surname>Tsai</surname> <given-names>PY</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>CY</given-names>
</name>
</person-group>. <article-title>Upregulation of miR-20b-5p inhibits trophoblast invasion by blocking autophagy in recurrent miscarriage</article-title>. <source>Cell signalling</source>. (<year>2024</year>) <volume>113</volume>:<fpage>110934</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cellsig.2023.110934</pub-id>, PMID: <pub-id pub-id-type="pmid">37871665</pub-id></citation></ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alzubaidi</surname> <given-names>KRK</given-names>
</name>
<name>
<surname>Mahdavi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dolati</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yousefi</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Observation of increased levels of autophagy-related genes and proteins in women with preeclampsia: a clinical study</article-title>. <source>Mol Biol Rep</source>. (<year>2023</year>) <volume>50</volume>:<page-range>4831&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11033-023-08385-6</pub-id>, PMID: <pub-id pub-id-type="pmid">37039997</pub-id></citation></ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname> <given-names>L</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Apelin/APJ system protects placental trophoblasts from hypoxia-induced oxidative stress through activating PI3K/Akt signaling pathway in preeclampsia</article-title>. <source>Free Radical Biol Med</source>. (<year>2023</year>) <volume>208</volume>:<page-range>759&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2023.09.030</pub-id>, PMID: <pub-id pub-id-type="pmid">37774802</pub-id></citation></ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Fierro</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Garza-Veloz</surname> <given-names>I</given-names>
</name>
<name>
<surname>Casta&#xf1;eda-Lopez</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Wasike</surname> <given-names>D</given-names>
</name>
<name>
<surname>la Rosa</surname> <given-names>CCD</given-names>
</name>
<name>
<surname>Rodriguez-Sanchez</surname> <given-names>IP</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluation of the effect of the fibroblast growth factor type 2 (FGF-2) administration on placental gene expression in a murine model of preeclampsia induced by L-NAME</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<fpage>10129</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms231710129</pub-id>, PMID: <pub-id pub-id-type="pmid">36077527</pub-id></citation></ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname> <given-names>BF</given-names>
</name>
<name>
<surname>Grenho</surname> <given-names>I</given-names>
</name>
<name>
<surname>Martel</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>BI</given-names>
</name>
<name>
<surname>Link</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>FOXO family isoforms</article-title>. <source>Cell Death disease</source>. (<year>2023</year>) <volume>14</volume>:<fpage>702</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-023-06177-1</pub-id>, PMID: <pub-id pub-id-type="pmid">37891184</pub-id></citation></ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aye</surname> <given-names>ILMH</given-names>
</name>
<name>
<surname>Aiken</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Charnock-Jones</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>GCS</given-names>
</name>
</person-group>. <article-title>Placental energy metabolism in health and disease&amp;x2014;significance of development and implications for preeclampsia</article-title>. <source>Am J Obstetrics Gynecology</source>. (<year>2022</year>) <volume>226</volume>:<page-range>S928&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajog.2020.11.005</pub-id>, PMID: <pub-id pub-id-type="pmid">33189710</pub-id></citation></ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yiew</surname> <given-names>NKH</given-names>
</name>
<name>
<surname>Finck</surname> <given-names>BN</given-names>
</name>
</person-group>. <article-title>The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism</article-title>. <source>Am J Physiol Endocrinol Metab</source>. (<year>2022</year>) <volume>323</volume>:<fpage>E33</fpage>&#x2013;<lpage>e52</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpendo.00074.2022</pub-id>, PMID: <pub-id pub-id-type="pmid">35635330</pub-id></citation></ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prochownik</surname> <given-names>EV</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>The metabolic fates of pyruvate in normal and neoplastic cells</article-title>. <source>Cells</source>. (<year>2021</year>) <volume>10</volume>:<fpage>762</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells10040762</pub-id>, PMID: <pub-id pub-id-type="pmid">33808495</pub-id></citation></ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Mai</surname> <given-names>W</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Dual roles of hexokinase 2 in shaping microglial function by gating glycolytic flux and mitochondrial activity</article-title>. <source>Nat Metab</source>. (<year>2022</year>) <volume>4</volume>:<page-range>1756&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s42255-022-00707-5</pub-id>, PMID: <pub-id pub-id-type="pmid">36536134</pub-id></citation></ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>HK2: Gatekeeping microglial activity by tuning glucose metabolism and mitochondrial functions</article-title>. <source>Mol Cell</source>. (<year>2023</year>) <volume>83</volume>:<page-range>829&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2023.02.022</pub-id>, PMID: <pub-id pub-id-type="pmid">36931254</pub-id></citation></ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Song</surname> <given-names>K</given-names>
</name>
<name>
<surname>He</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways</article-title>. <source>Cell Commun Signal</source>. (<year>2022</year>) <volume>20</volume>:<fpage>132</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12964-022-00943-y</pub-id>, PMID: <pub-id pub-id-type="pmid">36042519</pub-id></citation></ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siddique</surname> <given-names>AHH</given-names>
</name>
<name>
<surname>Kale</surname> <given-names>PP</given-names>
</name>
</person-group>. <article-title>Importance of glucose and its metabolism in neurodegenerative disorder, as well as the combination of multiple therapeutic strategies targeting &#x3b1;-synuclein and neuroprotection in the treatment of Parkinson's disease</article-title>. <source>Rev Neurologique</source>. (<year>2024</year>) <volume>180</volume>:<page-range>736&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.neurol.2023.08.011</pub-id>, PMID: <pub-id pub-id-type="pmid">38040547</pub-id></citation></ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duncan</surname> <given-names>L</given-names>
</name>
<name>
<surname>Shay</surname> <given-names>C</given-names>
</name>
<name>
<surname>Teng</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>PGK1: an essential player in modulating tumor metabolism</article-title>. <source>Methods Mol Biol (Clifton NJ)</source>. (<year>2022</year>) <volume>2343</volume>:<fpage>57</fpage>&#x2013;<lpage>70</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-0716-1558-4_4</pub-id>, PMID: <pub-id pub-id-type="pmid">34473315</pub-id></citation></ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Infantino</surname> <given-names>V</given-names>
</name>
<name>
<surname>Santarsiero</surname> <given-names>A</given-names>
</name>
<name>
<surname>Convertini</surname> <given-names>P</given-names>
</name>
<name>
<surname>Todisco</surname> <given-names>S</given-names>
</name>
<name>
<surname>Iacobazzi</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>:<fpage>5703</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms22115703</pub-id>, PMID: <pub-id pub-id-type="pmid">34071836</pub-id></citation></ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zuo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>W</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>HIF-1&#x3b1;/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury</article-title>. <source>Cell Mol Biol Lett</source>. (<year>2021</year>) <volume>26</volume>:<fpage>40</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s11658-021-00283-8</pub-id>, PMID: <pub-id pub-id-type="pmid">34479471</pub-id></citation></ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Islam</surname> <given-names>A</given-names>
</name>
<name>
<surname>Shaukat</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Hussain</surname> <given-names>R</given-names>
</name>
<name>
<surname>Gregory</surname> <given-names>SL</given-names>
</name>
</person-group>. <article-title>One-carbon and polyamine metabolism as cancer therapy targets</article-title>. <source>Biomolecules</source>. (<year>2022</year>) <volume>12</volume>:<fpage>1902</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biom12121902</pub-id>, PMID: <pub-id pub-id-type="pmid">36551330</pub-id></citation></ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Floc&#x2019;h</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nagashima</surname> <given-names>K</given-names>
</name>
<name>
<surname>Birchard</surname> <given-names>D</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ben</surname> <given-names>L-H</given-names>
</name>
<name>
<surname>Ajithdoss</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Blocking common &#x3b3; chain cytokine signaling ameliorates T cell&#x2013;mediated pathogenesis in disease models</article-title>. <source>Sci Trans Med</source>. (<year>2023</year>) <volume>15</volume>:<elocation-id>eabo0205</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/scitranslmed</pub-id>, PMID: <pub-id pub-id-type="pmid">36630481</pub-id></citation></ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Touyz</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Alves-Lopes</surname> <given-names>R</given-names>
</name>
<name>
<surname>Rios</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Camargo</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Anagnostopoulou</surname> <given-names>A</given-names>
</name>
<name>
<surname>Arner</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Vascular smooth muscle contraction in hypertension</article-title>. <source>Cardiovasc Res</source>. (<year>2018</year>) <volume>114</volume>:<page-range>529&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cvr/cvy023</pub-id>, PMID: <pub-id pub-id-type="pmid">29394331</pub-id></citation></ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>L</given-names>
</name>
<name>
<surname>Su</surname> <given-names>P</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>W</given-names>
</name>
<name>
<surname>Bi</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-9/STAT3/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity</article-title>. <source>J Clin Invest</source>. (<year>2022</year>) <volume>132</volume>:<fpage>e153247</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI153247</pub-id>, PMID: <pub-id pub-id-type="pmid">35192544</pub-id></citation></ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>F</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bian</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Ginseng root extract attenuates inflammation by inhibiting the MAPK/NF-&#x3ba;B signaling pathway and activating autophagy and p62-Nrf2-Keap1 signaling <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>J Ethnopharmacology</source>. (<year>2022</year>) <volume>283</volume>:<fpage>114739</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2021.114739</pub-id>, PMID: <pub-id pub-id-type="pmid">34648903</pub-id></citation></ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erdmann</surname> <given-names>KS</given-names>
</name>
<name>
<surname>Mao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>McCrea</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Zoncu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Paradise</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway</article-title>. <source>Dev Cell</source>. (<year>2007</year>) <volume>13</volume>:<page-range>377&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.devcel.2007.08.004</pub-id>, PMID: <pub-id pub-id-type="pmid">17765681</pub-id></citation></ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagemann</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Goody</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Itzen</surname> <given-names>A</given-names>
</name>
<name>
<surname>Erdmann</surname> <given-names>KS</given-names>
</name>
</person-group>. <article-title>Crystal structure of the Rab binding domain of OCRL1 in complex with Rab8 and functional implications of the OCRL1/Rab8 module for Lowe syndrome</article-title>. <source>Small Gtpases</source>. (<year>2012</year>) <volume>3</volume>:<page-range>107&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4161/sgtp.19380</pub-id>, PMID: <pub-id pub-id-type="pmid">22790198</pub-id></citation></ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Weber-Boyvat</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Oculocerebrorenal syndrome of Lowe (OCRL) controls leukemic T-cell survival by preventing excessive PI(4,5)P(2) hydrolysis in the plasma membrane</article-title>. <source>J Biol Chem</source>. (<year>2023</year>) <volume>299</volume>:<fpage>104812</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jbc.2023.104812</pub-id>, PMID: <pub-id pub-id-type="pmid">37172724</pub-id></citation></ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Nawaz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway</article-title>. <source>Acta Pharmacologica Sinica</source>. (<year>2011</year>) <volume>32</volume>:<page-range>1475&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/aps.2011.120</pub-id>, PMID: <pub-id pub-id-type="pmid">21986573</pub-id></citation></ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ampey</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Dahn</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Grummer</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Bird</surname> <given-names>IM</given-names>
</name>
</person-group>. <article-title>Differential control of uterine artery endothelial monolayer integrity by TNF and VEGF is achieved through multiple mechanisms operating inside and outside the cell - Relevance to preeclampsia</article-title>. <source>Mol Cell Endocrinol</source>. (<year>2021</year>) <volume>534</volume>:<fpage>111368</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mce.2021.111368</pub-id>, PMID: <pub-id pub-id-type="pmid">34153378</pub-id></citation></ref>
<ref id="B102">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kai</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Identifying preeclampsia-associated key module and hub genes via weighted gene co-expression network analysis</article-title>. <source>Sci Rep</source>. (<year>2025</year>) <volume>15</volume>:<fpage>1364</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-025-85599-7</pub-id>, PMID: <pub-id pub-id-type="pmid">39779839</pub-id></citation></ref>
<ref id="B103">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>B</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Prognostic prediction model for glioblastoma: A metabolic gene signature and independent external validation</article-title>. <source>J Cancer</source>. (<year>2021</year>) <volume>12</volume>:<page-range>3796&#x2013;808</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/jca.53827</pub-id>, PMID: <pub-id pub-id-type="pmid">34093788</pub-id></citation></ref>
<ref id="B104">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Glyceraldehyde-3-phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase</article-title>. <source>Hepatol (Baltimore Md)</source>. (<year>2017</year>) <volume>66</volume>:<page-range>631&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/hep.29202</pub-id>, PMID: <pub-id pub-id-type="pmid">28387968</pub-id></citation></ref>
<ref id="B105">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sirover</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>The role of posttranslational modification in moonlighting glyceraldehyde-3-phosphate dehydrogenase structure and function</article-title>. <source>Amino Acids</source>. (<year>2021</year>) <volume>53</volume>:<page-range>507&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00726-021-02959-z</pub-id>, PMID: <pub-id pub-id-type="pmid">33651246</pub-id></citation></ref>
<ref id="B106">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kornberg</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Bhargava</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Putluri</surname> <given-names>V</given-names>
</name>
<name>
<surname>Snowman</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Putluri</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity</article-title>. <source>Science</source>. (<year>2018</year>) <volume>360</volume>:<page-range>449&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.aan4665</pub-id>, PMID: <pub-id pub-id-type="pmid">29599194</pub-id></citation></ref>
<ref id="B107">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teng</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Williamson</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Hypoxia impairs NK cell cytotoxicity through SHP-1-mediated attenuation of STAT3 and ERK signaling pathways</article-title>. <source>J Immunol Res</source>. (<year>2020</year>) <volume>2020</volume>:<fpage>4598476</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2020/4598476</pub-id>, PMID: <pub-id pub-id-type="pmid">33123602</pub-id></citation></ref>
<ref id="B108">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>D</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Elevated PGT promotes proliferation and inhibits cell apoptosis in preeclampsia by Erk signaling pathway</article-title>. <source>Mol Cell Probes</source>. (<year>2023</year>) <volume>67</volume>:<fpage>101896</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mcp.2023.101896</pub-id>, PMID: <pub-id pub-id-type="pmid">36731680</pub-id></citation></ref>
<ref id="B109">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>X</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Augmentation of scleral glycolysis promotes myopia through histone lactylation</article-title>. <source>Cell Metab</source>. (<year>2024</year>) <volume>36</volume>:<fpage>511</fpage>&#x2013;<lpage>525.e517</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2023.12.023</pub-id>, PMID: <pub-id pub-id-type="pmid">38232735</pub-id></citation></ref>
<ref id="B110">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>P</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Ai</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated nuclear localization of glycolytic enzyme TPI1 promotes lung adenocarcinoma and enhances chemoresistance</article-title>. <source>Cell Death Dis</source>. (<year>2022</year>) <volume>13</volume>:<fpage>205</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-022-04655-6</pub-id>, PMID: <pub-id pub-id-type="pmid">35246510</pub-id></citation></ref>
<ref id="B111">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname> <given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression</article-title>. <source>Cancer Commun (Lond)</source>. (<year>2023</year>) <volume>43</volume>:<page-range>338&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cac2.12403</pub-id>, PMID: <pub-id pub-id-type="pmid">36602428</pub-id></citation></ref>
<ref id="B112">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>LDHA as a regulator of T cell fate and its mechanisms in disease</article-title>. <source>Biomedicine pharmacotherapy = Biomedecine pharmacotherapie</source>. (<year>2023</year>) <volume>158</volume>:<fpage>114164</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2022.114164</pub-id>, PMID: <pub-id pub-id-type="pmid">36916398</pub-id></citation></ref>
<ref id="B113">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>N</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>M</given-names>
</name>
<name>
<surname>Stamatiades</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Shyu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity</article-title>. <source>Science</source>. (<year>2021</year>) <volume>371</volume>:<page-range>405&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.abb2683</pub-id>, PMID: <pub-id pub-id-type="pmid">33479154</pub-id></citation></ref>
<ref id="B114">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Rong</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Dysregulated GLUT1 may be involved in the pathogenesis of preeclampsia by impairing decidualization</article-title>. <source>Mol Cell Endocrinology</source>. (<year>2022</year>) <volume>540</volume>:<fpage>111509</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mce.2021.111509</pub-id>, PMID: <pub-id pub-id-type="pmid">34801669</pub-id></citation></ref>
<ref id="B115">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burwick</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Feinberg</surname> <given-names>BB</given-names>
</name>
</person-group>. <article-title>Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome</article-title>. <source>Am J obstetrics gynecology</source>. (<year>2022</year>) <volume>226</volume>:<fpage>S1059</fpage>&#x2013;<lpage>s1070</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajog.2020.09.038</pub-id>, PMID: <pub-id pub-id-type="pmid">32986992</pub-id></citation></ref>
<ref id="B116">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Chaput</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sinkey</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Garces</surname> <given-names>AH</given-names>
</name>
<name>
<surname>New</surname> <given-names>EP</given-names>
</name>
<name>
<surname>Okuka</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Proteomic studies of VEGFR2 in human placentas reveal protein associations with preeclampsia, diabetes, gravidity, and labor</article-title>. <source>Cell communication signaling: CCS</source>. (<year>2024</year>) <volume>22</volume>:<fpage>221</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12964-024-01567-0</pub-id>, PMID: <pub-id pub-id-type="pmid">38594674</pub-id></citation></ref>
<ref id="B117">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deer</surname> <given-names>E</given-names>
</name>
<name>
<surname>Herrock</surname> <given-names>O</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>N</given-names>
</name>
<name>
<surname>Cornelius</surname> <given-names>D</given-names>
</name>
<name>
<surname>Fitzgerald</surname> <given-names>S</given-names>
</name>
<name>
<surname>Amaral</surname> <given-names>LM</given-names>
</name>
<etal/>
</person-group>. <article-title>The role of immune cells and mediators in preeclampsia</article-title>. <source>Nat Rev Nephrol</source>. (<year>2023</year>) <volume>19</volume>:<page-range>257&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41581-022-00670-0</pub-id>, PMID: <pub-id pub-id-type="pmid">36635411</pub-id></citation></ref>
<ref id="B118">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aneman</surname> <given-names>I</given-names>
</name>
<name>
<surname>Pienaar</surname> <given-names>D</given-names>
</name>
<name>
<surname>Suvakov</surname> <given-names>S</given-names>
</name>
<name>
<surname>Simic</surname> <given-names>TP</given-names>
</name>
<name>
<surname>Garovic</surname> <given-names>VD</given-names>
</name>
<name>
<surname>McClements</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Mechanisms of key innate immune cells in early- and late-onset preeclampsia</article-title>. <source>Front Immunol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>1864</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.01864</pub-id>, PMID: <pub-id pub-id-type="pmid">33013837</pub-id></citation></ref>
<ref id="B119">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nieves</surname> <given-names>C</given-names>
</name>
<name>
<surname>Victoria da Costa Ghignatti</surname> <given-names>P</given-names>
</name>
<name>
<surname>Aji</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bertagnolli</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Immune cells and infectious diseases in preeclampsia susceptibility</article-title>. <source>Can J Cardiol</source>. (<year>2024</year>) <volume>40</volume>:<page-range>2340&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cjca.2024.09.012</pub-id>, PMID: <pub-id pub-id-type="pmid">39304126</pub-id></citation></ref>
<ref id="B120">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>F</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1234577</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1234577</pub-id>, PMID: <pub-id pub-id-type="pmid">37854606</pub-id></citation></ref>
<ref id="B121">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dikshit</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Metabolic insight of neutrophils in health and disease</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>2099</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.02099</pub-id>, PMID: <pub-id pub-id-type="pmid">31616403</pub-id></citation></ref>
<ref id="B122">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yazdani</surname> <given-names>HO</given-names>
</name>
<name>
<surname>Roy</surname> <given-names>E</given-names>
</name>
<name>
<surname>Comerci</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>van der Windt</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Neutrophil extracellular traps drive mitochondrial homeostasis in tumors to augment growth</article-title>. <source>Cancer Res</source>. (<year>2019</year>) <volume>79</volume>:<page-range>5626&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-19-0800</pub-id>, PMID: <pub-id pub-id-type="pmid">31519688</pub-id></citation></ref>
<ref id="B123">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dyhia</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ahmad Haidar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Patrice</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Neutrophil extracellular traps (NET): not only antimicrobial but also modulators of innate and adaptive immunities in inflammatory autoimmune diseases</article-title>. <source>RMD Open</source>. (<year>2023</year>) <volume>9</volume>:<elocation-id>e003104</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/rmdopen-2023-003104</pub-id>, PMID: <pub-id pub-id-type="pmid">37562857</pub-id></citation></ref>
<ref id="B124">
<label>124</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Adair</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Weeks</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Lewis</surname> <given-names>DF</given-names>
</name>
<name>
<surname>Alexander</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia</article-title>. <source>J Soc Gynecol Investig</source>. (<year>1999</year>) <volume>6</volume>:<page-range>136&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1071-5576(99)00004-0</pub-id>, PMID: <pub-id pub-id-type="pmid">10376269</pub-id></citation></ref>
<ref id="B125">
<label>125</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Increased neutrophil activation and plasma DNA levels in patients with pre-eclampsia</article-title>. <source>Thromb Haemostasis</source>. (<year>2018</year>) <volume>118</volume>:<page-range>2064&#x2013;2073</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/s-0038-1675788</pub-id>, PMID: <pub-id pub-id-type="pmid">30453347</pub-id></citation></ref>
<ref id="B126">
<label>126</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Nugent</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Al Dulaimi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Washington</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Dacha</surname> <given-names>P</given-names>
</name>
<name>
<surname>Strauss</surname> <given-names>JF</given-names> <suffix>3rd</suffix>
</name>
<etal/>
</person-group>. <article-title>Proteases activate pregnancy neutrophils by a protease-activated receptor 1 pathway: epigenetic implications for preeclampsia</article-title>. <source>Reprod Sci</source>. (<year>2020</year>) <volume>27</volume>:<page-range>2115&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s43032-020-00232-4</pub-id>, PMID: <pub-id pub-id-type="pmid">32542542</pub-id></citation></ref>
<ref id="B127">
<label>127</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jing</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Shaheen</surname> <given-names>E</given-names>
</name>
<name>
<surname>Drake</surname> <given-names>RR</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gravenstein</surname> <given-names>S</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood</article-title>. <source>Hum Immunol</source>. (<year>2009</year>) <volume>70</volume>:<page-range>777&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.humimm.2009.07.005</pub-id>, PMID: <pub-id pub-id-type="pmid">19596035</pub-id></citation></ref>
<ref id="B128">
<label>128</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moldenhauer</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Diener</surname> <given-names>KR</given-names>
</name>
<name>
<surname>Thring</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Hayball</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Robertson</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy1</article-title>. <source>J Immunol</source>. (<year>2009</year>) <volume>182</volume>:<page-range>8080&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0804018</pub-id>, PMID: <pub-id pub-id-type="pmid">19494334</pub-id></citation></ref>
<ref id="B129">
<label>129</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>XY</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>TF</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>ZF</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Vascular endothelial growth factor affects dendritic cell activity in hypertensive disorders of pregnancy</article-title>. <source>Mol Med Rep</source>. (<year>2015</year>) <volume>12</volume>:<page-range>3781&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2015.3783</pub-id>, PMID: <pub-id pub-id-type="pmid">25975204</pub-id></citation></ref>
<ref id="B130">
<label>130</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panda</surname> <given-names>B</given-names>
</name>
<name>
<surname>Panda</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ueda</surname> <given-names>I</given-names>
</name>
<name>
<surname>Abrahams</surname> <given-names>VM</given-names>
</name>
<name>
<surname>Norwitz</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Stanic</surname> <given-names>AK</given-names>
</name>
<etal/>
</person-group>. <article-title>Dendritic cells in the circulation of women with preeclampsia demonstrate a pro-inflammatory bias secondary to dysregulation of TLR receptors</article-title>. <source>J Reprod Immunol</source>. (<year>2012</year>) <volume>94</volume>:<page-range>210&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jri.2012.01.008</pub-id>, PMID: <pub-id pub-id-type="pmid">22440523</pub-id></citation></ref>
<ref id="B131">
<label>131</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gierman</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>GB</given-names>
</name>
<name>
<surname>Pervaiz</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Rakner</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Mundal</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Thaning</surname> <given-names>AJ</given-names>
</name>
<etal/>
</person-group>. <article-title>TLR3 expression by maternal and fetal cells at the maternal-fetal interface in normal and preeclamptic pregnancies</article-title>. <source>J Leukocyte Biol</source>. (<year>2020</year>) <volume>109</volume>:<page-range>173&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/JLB.3MA0620-728RR</pub-id>, PMID: <pub-id pub-id-type="pmid">32573856</pub-id></citation></ref>
<ref id="B132">
<label>132</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrock</surname> <given-names>OT</given-names>
</name>
<name>
<surname>Deer</surname> <given-names>E</given-names>
</name>
<name>
<surname>Amaral</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lemon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ingram</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>B2 cells contribute to hypertension and natural killer cell activation possibly via AT1-AA in response to placental ischemia</article-title>. <source>Am J Physiol Renal Physiol</source>. (<year>2023</year>) <volume>324</volume>:<fpage>F179</fpage>&#x2013;<lpage>f192</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajprenal.00190.2022</pub-id>, PMID: <pub-id pub-id-type="pmid">36417275</pub-id></citation></ref>
<ref id="B133">
<label>133</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salby</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Persson</surname> <given-names>G</given-names>
</name>
<name>
<surname>Pedersen</surname> <given-names>NH</given-names>
</name>
<name>
<surname>Turan</surname> <given-names>G</given-names>
</name>
<name>
<surname>Kimmerslev</surname> <given-names>L</given-names>
</name>
<name>
<surname>Finne</surname> <given-names>KF</given-names>
</name>
<etal/>
</person-group>. <article-title>Reduced expression of programmed cell death protein 1 on peripheral regulatory B cells in pre-eclampsia &#x2013; Signs of impaired immune suppression</article-title>. <source>J Reprod Immunol</source>. (<year>2025</year>) <volume>168</volume>:<fpage>104426</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jri.2025.104426</pub-id>, PMID: <pub-id pub-id-type="pmid">39823688</pub-id></citation></ref>
<ref id="B134">
<label>134</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palma</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Hanes</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Marshall</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Mast cell modulation of B cell responses: an under-appreciated partnership in host defence</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>718499</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.718499</pub-id>, PMID: <pub-id pub-id-type="pmid">34566974</pub-id></citation></ref>
<ref id="B135">
<label>135</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Mast cell-derived exosomal miR-181a-5p modulated trophoblast cell viability, migration, and invasion via YY1/MMP-9 axis</article-title>. <source>J Clin Lab Anal</source>. (<year>2022</year>) <volume>36</volume>:<elocation-id>e24549</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcla.24549</pub-id>, PMID: <pub-id pub-id-type="pmid">35698293</pub-id></citation></ref>
<ref id="B136">
<label>136</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szewczyk</surname> <given-names>G</given-names>
</name>
<name>
<surname>Pyzlak</surname> <given-names>M</given-names>
</name>
<name>
<surname>Klimkiewicz</surname> <given-names>J</given-names>
</name>
<name>
<surname>Smiertka</surname> <given-names>W</given-names>
</name>
<name>
<surname>Miedzi&#x144;ska-Maciejewska</surname> <given-names>M</given-names>
</name>
<name>
<surname>Szukiewicz</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Mast cells and histamine: do they influence placental vascular network and development in preeclampsia</article-title>? <source>Mediators Inflammation</source>. (<year>2012</year>) <volume>2012</volume>:<fpage>307189</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2012/307189</pub-id>, PMID: <pub-id pub-id-type="pmid">22778495</pub-id></citation></ref>
<ref id="B137">
<label>137</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pawankar</surname> <given-names>R</given-names>
</name>
<name>
<surname>Okuda</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yssel</surname> <given-names>H</given-names>
</name>
<name>
<surname>Okumura</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ra</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells</article-title>. <source>J Clin Invest</source>. (<year>1997</year>) <volume>99</volume>:<page-range>1492&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI119311</pub-id>, PMID: <pub-id pub-id-type="pmid">9119992</pub-id></citation></ref>
<ref id="B138">
<label>138</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breitling</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hui</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zabini</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hoffmann</surname> <given-names>J</given-names>
</name>
<name>
<surname>Goldenberg</surname> <given-names>NM</given-names>
</name>
<etal/>
</person-group>. <article-title>The mast cell&#x2013;B cell axis in lung vascular remodeling and pulmonary hypertension</article-title>. <source>Am J Physiology-Lung Cell Mol Physiol</source>. (<year>2017</year>) <volume>312</volume>:<page-range>L710&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajplung.00311.2016</pub-id>, PMID: <pub-id pub-id-type="pmid">28235950</pub-id></citation></ref>
</ref-list>
</back>
</article>